b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2692245/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692245/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Nature Structural &amp; Molecular Biology" /><meta name="citation_title" content="Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses" /><meta name="citation_authors" content="Jianhua Sui, William C Hwang, Sandra Perez, Ge Wei, Daniel Aird, Li-mei Chen, Eugenio Santelli, Boguslaw Stec, Greg Cadwell, Maryam Ali, Hongquan Wan, Akikazu Murakami, Anuradha Yammanuru, Thomas Han, Nancy J Cox, Laurie A Bankston, Ruben O Donis, Robert C Liddington, Wayne A Marasco" /><meta name="citation_date" content="2009" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="16" /><meta name="citation_firstpage" content="265" /><meta name="citation_doi" content="10.1038/nsmb.1566" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2692245/?report=abstract" /><meta name="citation_pmid" content="19234466" /><meta name="DC.Title" content="Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Jianhua Sui" /><meta name="DC.Contributor" content="William C Hwang" /><meta name="DC.Contributor" content="Sandra Perez" /><meta name="DC.Contributor" content="Ge Wei" /><meta name="DC.Contributor" content="Daniel Aird" /><meta name="DC.Contributor" content="Li-mei Chen" /><meta name="DC.Contributor" content="Eugenio Santelli" /><meta name="DC.Contributor" content="Boguslaw Stec" /><meta name="DC.Contributor" content="Greg Cadwell" /><meta name="DC.Contributor" content="Maryam Ali" /><meta name="DC.Contributor" content="Hongquan Wan" /><meta name="DC.Contributor" content="Akikazu Murakami" /><meta name="DC.Contributor" content="Anuradha Yammanuru" /><meta name="DC.Contributor" content="Thomas Han" /><meta name="DC.Contributor" content="Nancy J Cox" /><meta name="DC.Contributor" content="Laurie A Bankston" /><meta name="DC.Contributor" content="Ruben O Donis" /><meta name="DC.Contributor" content="Robert C Liddington" /><meta name="DC.Contributor" content="Wayne A Marasco" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1038/nsmb.1566" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses" /><meta property="og:type" content="article" /><meta property="og:description" content="Influenza virus remains a serious health threat, owing to its ability to evade immune surveillance through rapid genetic drift and reassortment. Here we used a human non-immune antibody phage-display library and the H5 hemagglutinin ectodomain to select ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692245/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2692245/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2692245/pdf/41594_2009_Article_BFnsmb1566.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A0E58E99C766100000000025F025E.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2692245</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg" style="font-size:20px;line-height:2.4;">Nature Structural &#x00026; Molecular Biology</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Nat Struct Mol Biol</span>. 2009; 16(3): 265\xe2\x80\x93273. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Feb 22. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1038%2Fnsmb.1566" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1038/nsmb.1566</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2692245</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span><a class="int-reflink" href="/pmc/articles/mid/NIHMS103240/">NIHMS103240</a></span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19234466">19234466</a></div></div></div></div><h1 class="content-title">Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Sui%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978425826016" co-class="co-affbox">Jianhua Sui</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>#</sup><sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Hwang%20WC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978428141424" co-class="co-affbox">William C Hwang</a>,<sup>#</sup><sup>2</sup> <a href="/pubmed/?term=Perez%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978461320320" co-class="co-affbox">Sandra Perez</a>,<sup>3</sup> <a href="/pubmed/?term=Wei%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978424956704" co-class="co-affbox">Ge Wei</a>,<sup>2</sup> <a href="/pubmed/?term=Aird%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978424954720" co-class="co-affbox">Daniel Aird</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Chen%20Lm%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978463756304" co-class="co-affbox">Li-mei Chen</a>,<sup>3</sup> <a href="/pubmed/?term=Santelli%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978463754320" co-class="co-affbox">Eugenio Santelli</a>,<sup>2</sup> <a href="/pubmed/?term=Stec%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978423134864" co-class="co-affbox">Boguslaw Stec</a>,<sup>2</sup> <a href="/pubmed/?term=Cadwell%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978417454064" co-class="co-affbox">Greg Cadwell</a>,<sup>2</sup> <a href="/pubmed/?term=Ali%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978417452192" co-class="co-affbox">Maryam Ali</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Wan%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978463801776" co-class="co-affbox">Hongquan Wan</a>,<sup>3</sup> <a href="/pubmed/?term=Murakami%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978463799792" co-class="co-affbox">Akikazu Murakami</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Yammanuru%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978424990064" co-class="co-affbox">Anuradha Yammanuru</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Han%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978500145696" co-class="co-affbox">Thomas Han</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Cox%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978500142976" co-class="co-affbox">Nancy J Cox</a>,<sup>3</sup> <a href="/pubmed/?term=Bankston%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978423154128" co-class="co-affbox">Laurie A Bankston</a>,<sup>2</sup> <a href="/pubmed/?term=Donis%20RO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978423152144" co-class="co-affbox">Ruben O Donis</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>3</sup> <a href="/pubmed/?term=Liddington%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978419887760" co-class="co-affbox">Robert C Liddington</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>2</sup> and  <a href="/pubmed/?term=Marasco%20WA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466" class="affpopup" co-rid="_co_idm139978420253472" co-class="co-affbox">Wayne A Marasco</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>4</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139978425826016"><h3 class="no_margin">Jianhua Sui</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Sui%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Jianhua Sui</a></div></div><div id="_co_idm139978428141424"><h3 class="no_margin">William C Hwang</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Hwang%20WC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">William C Hwang</a></div></div><div id="_co_idm139978461320320"><h3 class="no_margin">Sandra Perez</h3><p><sup>3</sup>Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, Mail Stop G-16, Atlanta, 30333 Georgia USA </p><div>Find articles by <a href="/pubmed/?term=Perez%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Sandra Perez</a></div></div><div id="_co_idm139978424956704"><h3 class="no_margin">Ge Wei</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Wei%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Ge Wei</a></div></div><div id="_co_idm139978424954720"><h3 class="no_margin">Daniel Aird</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Aird%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Daniel Aird</a></div></div><div id="_co_idm139978463756304"><h3 class="no_margin">Li-mei Chen</h3><p><sup>3</sup>Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, Mail Stop G-16, Atlanta, 30333 Georgia USA </p><div>Find articles by <a href="/pubmed/?term=Chen%20Lm%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Li-mei Chen</a></div></div><div id="_co_idm139978463754320"><h3 class="no_margin">Eugenio Santelli</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Santelli%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Eugenio Santelli</a></div></div><div id="_co_idm139978423134864"><h3 class="no_margin">Boguslaw Stec</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Stec%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Boguslaw Stec</a></div></div><div id="_co_idm139978417454064"><h3 class="no_margin">Greg Cadwell</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Cadwell%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Greg Cadwell</a></div></div><div id="_co_idm139978417452192"><h3 class="no_margin">Maryam Ali</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Ali%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Maryam Ali</a></div></div><div id="_co_idm139978463801776"><h3 class="no_margin">Hongquan Wan</h3><p><sup>3</sup>Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, Mail Stop G-16, Atlanta, 30333 Georgia USA </p><div>Find articles by <a href="/pubmed/?term=Wan%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Hongquan Wan</a></div></div><div id="_co_idm139978463799792"><h3 class="no_margin">Akikazu Murakami</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Murakami%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Akikazu Murakami</a></div></div><div id="_co_idm139978424990064"><h3 class="no_margin">Anuradha Yammanuru</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Yammanuru%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Anuradha Yammanuru</a></div></div><div id="_co_idm139978500145696"><h3 class="no_margin">Thomas Han</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Han%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Thomas Han</a></div></div><div id="_co_idm139978500142976"><h3 class="no_margin">Nancy J Cox</h3><p><sup>3</sup>Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, Mail Stop G-16, Atlanta, 30333 Georgia USA </p><div>Find articles by <a href="/pubmed/?term=Cox%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Nancy J Cox</a></div></div><div id="_co_idm139978423154128"><h3 class="no_margin">Laurie A Bankston</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Bankston%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Laurie A Bankston</a></div></div><div id="_co_idm139978423152144"><h3 class="no_margin">Ruben O Donis</h3><p><sup>3</sup>Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, Mail Stop G-16, Atlanta, 30333 Georgia USA </p><div>Find articles by <a href="/pubmed/?term=Donis%20RO%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Ruben O Donis</a></div></div><div id="_co_idm139978419887760"><h3 class="no_margin">Robert C Liddington</h3><p><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </p><div>Find articles by <a href="/pubmed/?term=Liddington%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Robert C Liddington</a></div></div><div id="_co_idm139978420253472"><h3 class="no_margin">Wayne A Marasco</h3><p><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </p><p><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </p><div>Find articles by <a href="/pubmed/?term=Marasco%20WA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19234466">Wayne A Marasco</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139978422060064_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139978422060064_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139978422060064_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139978422060064_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Department of Cancer Immunology &#x00026; AIDS, Dana-Farber Cancer Institute, , </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>Department of Medicine, Harvard Medical School, 44 Binney Street JFB 826, Boston, 02115 Massachusetts USA </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Infectious and Inflammatory Disease Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, 92037 California USA </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road, Mail Stop G-16, Atlanta, 30333 Georgia USA </div><div><span class="fm-affl">Jianhua Sui, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.icfd@ius_auhnaij" class="oemail">ude.dravrah.icfd@ius_auhnaij</a></span>.</div><div><a href="#idm139978422060064aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139978422060064_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Nov 18; Accepted 2009 Jan 22.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139978422060064_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Nature Publishing Group 2009</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2692245/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2>Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Text and Figures Supplementary Figures 1&#x02013;9, Supplementary Tables 1&#x02013;3, Supplementary Notes 1&#x02013;6 and Supplementary Methods (PDF 847 kb)</div><div><a href="/pmc/articles/PMC2692245/bin/41594_2009_BFnsmb1566_MOESM13_ESM.pdf" data-ga-action="click_feat_suppl">41594_2009_BFnsmb1566_MOESM13_ESM.pdf</a><span style="color:gray"> (848K)</span></div><div class="small guid">GUID:\xc2\xa0F5C954EA-19D0-424D-B2C8-A4B883EA4627</div></div></dd></dl></div><div id="Abs2" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs2title">Abstract</h2><!--article-meta--><div><p id="Par2" class="p p-first">Influenza virus remains a serious health threat, owing to its ability to evade immune surveillance through rapid genetic drift and reassortment. Here we used a human non-immune antibody phage-display library and the H5 hemagglutinin ectodomain to select ten neutralizing antibodies (nAbs) that were effective against all group 1 influenza viruses tested, including H5N1 \'bird flu\' and the H1N1 \'Spanish flu\'. The crystal structure of one such nAb bound to H5 shows that it blocks infection by inserting its heavy chain into a conserved pocket in the stem region, thus preventing membrane fusion. Nine of the nAbs employ the germline gene <em>VH1-69</em>, and all seem to use the same neutralizing mechanism. Our data further suggest that this region is recalcitrant to neutralization escape and that nAb-based immunotherapy is a promising strategy for broad-spectrum protection against seasonal and pandemic influenza viruses.</p><div id="__sec2" class="sec"><h3 id="__sec2title">Supplementary information</h3><p id="__p2" class="p p-first-last">The online version of this article (doi:10.1038/nsmb.1566) contains supplementary material, which is available to authorized users.</p></div></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Main</h2><p id="Par3" class="p p-first">Seasonal influenza A is a scourge of the young and old, killing more than 250,000 worldwide each year, while creating an economic burden for millions<sup><a href="#CR1" rid="CR1" class=" bibr popnode">1</a></sup>. Pandemic influenza, which occurs when a new virus emerges and infects people globally that have little or no immunity, represents a grave threat to human health; for example, the 1918 Spanish Flu pandemic caused an estimated 50 million deaths<sup><a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820287">2</a>,<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820316">3</a></sup>. Vaccines have historically been the mainstay of infection control. However, owing to rapid antigenic drift, the vaccine antigen must be updated annually based on global influenza surveillance<sup><a href="#CR4" rid="CR4" class=" bibr popnode">4</a>,<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820294">5</a></sup>, and it is not always fully successful. In addition, some recent H5N1 vaccines have shown promising results<sup><a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820270">6</a>,<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820296">7</a>,<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820298">8</a>,<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820323">9</a></sup>, but none has been reported to elicit a broad neutralizing response in humans. Neuraminidase inhibitors, especially oseltamavir (Tamiflu), remain the primary treatment, but they have limited efficacy if administered late in infection, and widespread use is likely to result in the emergence of resistant viral strains<sup><a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820324">10</a>,<a href="#CR11" rid="CR11" class=" bibr popnode">11</a></sup>.</p><p id="Par4">Influenza A is subclassified by its two major surface proteins: hemagglutinin, which mediates cell entry, first by recognizing host proteins bearing sialic acid on their surface, and second by triggering the fusion of viral and host membranes following endocytosis, allowing viral RNA to enter the cytoplasm; and neuraminidase, which cleaves sialic acid from host and viral proteins, facilitating cell exit<sup><a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup>. There are 16 hemagglutinin subtypes (H1&#x02013;16) and 9 neuraminidase subtypes (N1&#x02013;9) that make up all known strains of influenza A viruses by various combinations of hemagglutinin and neuraminidase<sup><a href="#CR12" rid="CR12" class=" bibr popnode">12</a></sup> (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 1</a> online).</p><p id="Par5">The recent spread of highly pathogenic avian influenza (HPAI), caused by the H5N1 strain, across Asia, Europe and Africa raises the specter of a new pandemic, should the virus mutate to become readily transmissible from person to person. The evolution of H5N1 into a pandemic threat could occur through a single reassortment of its segmented genome or through the slower process of genetic drift<sup><a href="#CR12" rid="CR12" class=" bibr popnode">12</a>,<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820284">13</a></sup>. Nearly 400 human H5N1 infections have been reported since 1997 from 14 countries, with a case mortality rate in the immunocompetent population above 60%<sup><a href="#CR4" rid="CR4" class=" bibr popnode">4</a></sup>.</p><p id="Par6">New therapeutic strategies that provide potent and broadly cross-protective host immunity are therefore a global public health priority. Human mAb-based \'passive\' immunotherapy is now being used to treat numerous human diseases, including respiratory syncytial virus infection, and we have proposed how immunotherapy could be used strategically in a viral outbreak setting<sup><a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820322">14</a></sup>.</p><p id="Par7" class="p p-last">In the present study, we first used a phage-display antibody library and recombinant H5 trimeric ectodomain to isolate a group of high-affinity nAbs that were potent inhibitors of H5N1 viral infection <em>in vitro</em> and <em>in vivo</em>. On the basis of crystallographic and functional studies, we showed that the nAbs bind to a common epitope&#x02014;a highly conserved pocket in the stem region of hemagglutinin containing the \'fusion peptide\'&#x02014;that rationalizes their ability to block membrane fusion rather than cell attachment. Sequence and structural analysis of all 16 hemagglutinin subtypes point to the existence of just two variants of this epitope, corresponding to the two classic phylogenetic groupings of hemagglutinin (groups 1 and 2). We therefore tested eight more group 1 hemagglutinin subtypes and demonstrated an unprecedented cross-subtype binding and/or neutralization spectrum. Because we had used a group 1 subtype (H5) for our panning, our nAbs, as expected, failed to neutralize group 2 subtypes H3 and H7. These results nevertheless raise the possibility that a cocktail comprising a small subset of nAbs raised against representatives of the two groups could provide broad protection against all seasonal and pandemic influenza A viruses.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Identification of nAbs against H5N1</h3><p id="Par8" class="p p-first">The current H5N1 epidemics involve viruses derived from a single lineage of H5 hemagglutinin. Within this lineage, four distinct clades have been identified as major threats to public health<sup><a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845250313">15</a>,<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845250311">16</a></sup>. We expressed recombinant trimeric ectodomain of H5 hemagglutinin from one of these viruses (strain A/Vietnam/1203/04 (H5N1), \'H5-VN04\', clade 1) in insect cells<sup><a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820301">17</a></sup> (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 2</a> online), immobilized it on a plastic surface and selected antibodies from a \'non-immune\' human antibody phage-display library (using single-chain VH-VL fragments (\'scFv\'))<sup><a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820299">18</a></sup>. Two rounds of panning and the screening of 392 clones identified 10 unique antibodies formed by six distinct VH (variable region of heavy chain) fragments in combination with ten different VL (variable region of light chain) fragments (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Table 1</a> online).</p><p id="Par9" class="p p-last">We found that all ten nAbs bound trimeric H5-VN04 with similar avidity, but did not bind monomeric HA1 (<a href="/pmc/articles/PMC2692245/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>Fig. 1a</span></a>). Presented as scFv-Fc constructs, they potently neutralized the clade 1 H5 pseudovirus, A/Thailand/2-SP-33/2004 (H5N1) (\'H5-TH04\') (<a href="/pmc/articles/PMC2692245/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>Fig. 1b</span></a>); and, in a stringent plaque-reduction assay, they all showed high levels of neutralization against H5-VN04, as well as the more divergent (clade 2.1) A/Indonesia/5/2005 (\'H5-IN05\') (<a href="/pmc/articles/PMC2692245/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>Fig. 1c,d</span></a>). We further found that the nAbs cross-competed with each other in a competition enzyme-linked immunosorbent assay (ELISA; <a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 3</a> online), suggesting that they share a common epitope. On the basis of this finding, as well as VH sequence diversity and neutralization potency, we converted three of the nAbs (D8, F10 and A66) into full-length human IgG1s for further studies; all three IgG1s bound to recombinant H5-VN04 with high affinity (<em>K</em><sub>d</sub> &#x0223c;100&#x02013;200 pM) and slow dissociation rates (<em>k</em><sub>d</sub> &#x0223c;10<sup>&#x02212;4</sup>s<sup>&#x02212;1</sup>) (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 4</a> online).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2692245/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978418182448" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig1_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig1_HTML.jpg" /></div><div id="largeobj_idm139978418182448" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>In vitro</em> binding and neutralization of anti-H5 antibodies.</strong><p id="__p3">(<strong>a</strong>) The ten antibodies were converted to soluble scFv-Fcs (scFv linked to the hinge, CH2 and CH3 domains of human IgG1) and evaluated for binding to trimeric H5-TH04 or monomeric HA1 of H5-TH04 coated on an ELISA plate. The H5 scFv-Fcs recognize trimeric H5 but not HA1. An antibody raised against HA1 (2A) recognized both. (<strong>b</strong>) Neutralization of H5-TH04&#x02013;pseudotyped viruses (virus-like particles with HIV-1 only cores that display H5 on their surface). Percentage of neutralization at two concentrations is shown with s.d. The mAb 80R<sup><a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820331">18</a></sup> was used as a negative control (Ctrl.). (<strong>c,d</strong>) Neutralization of wild-type H5-VN04 and H5-IN05 by the ten scFv-Fcs at three concentrations using a plaque reduction assay. Results are consistent with those obtained from a microneutralization assay (data not shown).</p></div></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">Prophylactic and therapeutic efficacy in mice</h3><p id="Par10" class="p p-first">We evaluated the protective efficacy of the three IgG1s against H5N1 virus infection in a BALB/c mouse model (<a href="/pmc/articles/PMC2692245/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>Fig. 2</span></a>). Mice were treated with IgG1s before (prophylactically) or after (therapeutically) lethal viral challenge. Prophylaxis using 10 mg kg<sup>&#x02212;1</sup> of IgG1s effectively protected (80&#x02013;100%) mice when challenged with a high lethal dose of H5-VN04 (clade 1) or A/HongKong/483/97 (\'H5-HK97\') (clade 0) (<a href="/pmc/articles/PMC2692245/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>Fig. 2a,b</span></a>). Therapeutic treatment with 15 mg kg<sup>&#x02212;1</sup> (an achievable dose in humans) of IgG1 24 h post-inoculation (hpi) also protected 80&#x02013;100% of the mice challenged with either H5-VN04 or H5-HK97 virus (<a href="/pmc/articles/PMC2692245/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>Fig. 2c,d</span></a>). Mice treated at later times (48 hpi or 72 hpi) with H5-VN04 showed similar or higher levels of protection (<a href="/pmc/articles/PMC2692245/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>Fig. 2e,f</span></a>). Furthermore, surviving mice remained healthy and showed minimal body weight loss over the 2-week observation period (data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2692245/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978419507712" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig2_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig2_HTML.jpg" /></div><div id="largeobj_idm139978419507712" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Prophylactic and therapeutic efficacy of anti-H5 nAbs in mice.</strong><p id="__p4">(<strong>a,b</strong>) Prophylactic efficacy. Percentage of survival of mice treated with anti-H5 nAbs or control mAb 1 h before lethal challenge by intranasal inoculation with H5-VN04 (<strong>a</strong>) or H5-HK97 (<strong>b</strong>) viruses. (<strong>c</strong>&#x02013;<strong>f</strong>). Therapeutic efficacy. Mice were inoculated with H5-VN04 and injected with nAbs at 24 h, 48 h of 72 hpi (<strong>c,e,f</strong>) or with H5-HK97 at 24 hpi (<strong>d</strong>).</p></div></div></div><p id="Par11" class="p p-last">Whereas human influenza viruses are typically restricted to the upper respiratory tract, systemic spread is a typical outcome of H5N1 infection in mice, and it has been reported in some humans. We found that the three IgG1s caused potent suppression of viral replication in the lungs (measured 4 d after viral challenge) of mice treated within 48 h of viral challenge; and that two IgG1s, F10 and A66, were effective when given at 72 hpi. The strong impact of antibody therapy on systemic infection was demonstrated by &#x02265;1,000-fold suppression of virus spread to the spleen, even when given 72 hpi (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 5</a> online). We also observed suppression in the brain, but in this case, systemic spread was too low in control animals for accurate quantitation.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">nAbs inhibit cell fusion rather than receptor binding</h3><p id="Par12" class="p p-first-last">Two ways in which anti-hemagglutinin antibodies can neutralize infection is by blocking the initial binding of hemagglutinin to its cellular receptor (sialic acid) or by interfering with the subsequent step of hemagglutinin-mediated virus-host membrane fusion, which occurs in acidic endosomes<sup><a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820335">19</a>,<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820272">20</a></sup>. We found that none of the nAbs inhibited virus binding to cells (<a href="/pmc/articles/PMC2692245/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>Fig. 3a</span></a>) or hemagglutination of red blood cells (data not shown). However, we were able to show, using a model system of cell fusion, that the nAbs potently inhibited membrane fusion (<a href="/pmc/articles/PMC2692245/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>Fig. 3b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2692245/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978420243376" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig3_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig3_HTML.jpg" /></div><div id="largeobj_idm139978420243376" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Neutralization mechanism.</strong><p id="__p5">(<strong>a</strong>) nAbs do not inhibit cell binding of full-length hemagglutinin from H5-TH04&#x02013;pseudotyped HIV-1 viruses. None of the three nAb-treated viruses inhibited cell binding. Mouse anti-H5 mAb, 17A2.1.2 and ferret anti-H5N1 serum, which inhibit hemagglutination, were used as positive controls. Anti-SARS spike protein (80R) and anti-HA1 (2A) were used as negative controls. Error bars represent s.d. (<strong>b</strong>) All three nAbs inhibit cell fusion. HeLa cells were transfected with H5-TH04&#x02013;expressing plasmid and exposed to a pH 5.0 buffer for 4 min in the presence or absence of nAbs. Syncytia formation induced by the brief exposure to pH 5.0 was completely inhibited by D8, F10 and A66, at 20 &#x003bc;g ml<sup>&#x02212;1</sup> (&#x0223c;0.13 &#x003bc;M), whereas controls (80R and anti-HA1 mAb (2A) at the same concentration had no effect.</p></div></div></div></div><div id="Sec6" class="sec"><h3 id="Sec6title">Structural characterization of the nAb epitope</h3><p id="Par13" class="p p-first">To provide a structural basis for neutralization and to explore the prospects for developing even broader-spectrum therapeutics, we determined the crystal structure of F10 (as the scFv fragment) in complex with the H5 (H5-VN04) ectodomain (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Fig. 4</span></a> and <a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Table 2</a> online). We used H5 activated by cleavage of the single-chain precursor, HA0, into two polypeptides, HA1 and HA2. Cleavage leads to the partial burial of the fusion peptide (the first &#x0223c;21 residues of each HA2) into the stem<sup><a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820279">19</a>,<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820327">21</a></sup>, which also contributes to the formation of each of three hydrophobic \'pockets\' located below the large trimeric receptor binding head. In the complex, one F10 nAb binds into each pocket, burying &#x0223c;1,500 &#x000c5;<sup>2</sup> of protein surface. Only the heavy chain (VH) participates directly in binding, using all three of its complementarity-determining regions (CDRs). The light chain (VL) points out into solution and makes only nonspecific contacts with the distal end of the oligosaccharide of glycosylated residue Asn33<sub>1</sub> from a neighboring monomer. The epitope on H5 encompasses the entire pocket, which is formed by the HA2 fusion peptide flanked by elements of HA1 on one side and helix &#x003b1;A of HA2 on the other.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978465459216" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig4_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig4_HTML.jpg" /></div><div id="largeobj_idm139978465459216" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Structure of the H5&#x02013;F10 complex.</strong><p id="__p6">(<strong>a</strong>) Structure of the H5 trimer bound to F10 (scFv). H5 is similar to the uncomplexed structure<sup><a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820275">35</a></sup> (pairwise r.m.s. deviation (C&#x003b1;) = 1.0 and 0.63 &#x000c5; for two independent trimers). HA1, HA2, the &#x003b1;A helix of HA2, the fusion peptide (FP) and F10 (VH and VL) are color coded. The third F10 molecule is hidden behind the stem. (<strong>b</strong>) Close-up of the epitope showing H5 as a molecular surface, with selected epitope residues labeled. The fusion peptide is in green. The tip of F10 (red ribbon) and selected CDR side chains are shown. Of 1,500 &#x000c5;<sup>2</sup> buried surface at the interface, 43% involves hydrophobic interactions. (<strong>c</strong>) Surface of the central stem region, showing two H5 monomers. One monomer has HA1 (yellow) and HA2 (blue) colored differently; the path of the FP through the epitope (red) is outlined, and mutations that do not affect binding are colored cyan (Fig. 4d). The fusion peptides (FP and FP&#x02032;) are labeled in both monomers. Epitope residues are labeled white (HA2) or yellow (HA1), and the position of buried residue H111<sub>2</sub> is shown as a black ball labeled \'H\'. (<strong>d</strong>) Binding of the three nAbs to H5 mutants in the &#x003b1;A helix, transiently transfected into 293T cells. Note the similar response to all mutants tested. Mutations were made either to alanine or to the corresponding H7 residue; 24 h after transfection, nAbs or ferret anti-H5N1 serum was used to stain the transfected cells. Fluorescent intensity was normalized against ferret anti-serum (100%) to account for different expression levels.</p></div></div></div><p id="Par14">The key interactions are as follows (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Fig. 4b</span></a>). (i) CDR-H2 adopts the \'type 2\' conformation<sup><a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820305">22</a></sup>. Two hydrophobic residues, Met54 and Phe55, from the tip of H2 insert into the pocket. Phe55 lies across a flat hydrophobic surface formed by the main chain of the fusion peptide, residues 18<sub>2</sub>&#x02013;21<sub>2</sub>; it also makes favorable orthogonal aromatic interactions<sup><a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820326">23</a></sup> with the side chains of Trp21<sub>2</sub> at the back of the pocket and His18<sub>1</sub> at the front (subscripts 1 or 2 refer to HA1 or HA2, and the numbering scheme follows the structure of H3 (PDB <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2HMG" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2HMG</a>)<sup><a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820289">17</a>,<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820295">24</a></sup>). The Met54 sulfur makes &#x003a0;&#x02212;aromatic interactions<sup><a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820290">25</a></sup> with the Trp21<sub>2</sub> ring, hydrophobic interactions with Ile45<sub>2</sub> from helix &#x003b1;A and a hydrogen bond between Met54 C=O and the His38<sub>1</sub> side chain. (ii) Tyr102 from CDR-H3 extends from the apex of the H3 loop to a location only &#x0223c;3 &#x000c5; from Phe55, and it complements CDR-H2 by cementing together the fusion peptide (via a main chain hydrogen bond to Asp19<sub>2</sub>) and the &#x003b1;A helix of HA2 (by intercalating between Thr41<sub>2</sub> and Ile45<sub>2</sub>). A large hydrophobic residue at the neighboring position 103 supports the side chain conformation of Tyr102. (iii) The CDR-H1 loop is characterized by small hydrophobic or polar side chains (notably Val27, Thr28 and Ser31) such that CDR-H1 fits snugly beneath the hemagglutinin head while packing against helix &#x003b1;A. A somatic mutation of conserved Gly26, G26E, generates a noncanonical conformation for H1, with Thr27 pointing outward and making contact H5.</p><p id="Par15">An N-terminal hairpin (residues Ile29<sub>2</sub> and Met30<sub>2</sub>) from HA2 of the counterclockwise neighbor packs against the other side of helix &#x003b1;A at this point, wrapping around its fusion peptide and further locking it into place (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Fig. 4a,c</span></a>). Thus, the F10 nAb may stabilize the fusion peptide of more than one subunit. One framework (FR3) residue, Gln74, seems to be especially important in stabilizing the CDR-H1 and CDR-H2 loop conformations, by forming hydrogen bonds to the main chain C = O groups of Pro53 and Met54, as well as the side chain of Ser30. The FR3 residue at position 72 is the major determinant of the choice between two distinct conformations of the H2 loop<sup><a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820328">22</a></sup>.</p><p id="Par16" class="p p-last">Consistent with the structural data, mutations in three H5 residues on HA2 &#x003b1;A, Val52<sub>2</sub>, Asn53<sub>2</sub> and Ile56<sub>2</sub>, which make important interactions with F10, greatly reduce or ablate nAb binding, whereas the conservative mutation V52L has no effect (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Fig. 4c,d</span></a>). Mutations to other surfaces of the &#x003b1;A helix either have no effect (typically exposed residues) or lead to increased nAb binding, perhaps by subtly increasing the flexibility of the epitope (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Fig. 4d</span></a>). Notably, the nine other nAbs show similar mutant binding profiles. Together with the cross-competition noted above, this strongly suggests that the epitopes for all ten nAbs overlap very closely indeed, and that the nAbs bind in a similar location and orientation.</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Structural basis of H5 neutralization by the nAb panel</h3><p id="Par17" class="p p-first">The broad neutralizing behavior against H5 may be attributed in part to the exclusive role of VH in antigen binding and the use of a common germline gene, <em>VH1-69</em>, in five out of the six VHs, although their CDR3 loops are variable in sequence and length (13&#x02013;17 residues) (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 6</a> and <a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Table 1</a> online). In addition, free-energy calculations<sup><a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820329">26</a></sup> point to dominant binding contributions (&#x0223c;70% of the total favorable free energy) of the three conserved residues in the VH segment (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Fig. 4b</span></a>). In CDR-H2 derived from germline <em>VH1-69</em>, position 55 is always phenylalanine, and position 54 is always hydrophobic (methionine, isoleucine, leucine or valine). In our nAbs, CDR-H3 always has a tyrosine predicted to lie at the tip of the CDR3 loop (conserved at the position 6). The conformation and sequence of the CDR1 loop does not seem to be critical, because the other antibodies we isolated do not contain the somatic mutation (G26E) found in F10 and are predicted to have canonical structures. The sixth VH gene we isolated is derived from the germline gene <em>VH1-2</em>; its H2 loop has the same length as <em>VH1-69</em>, but by virtue of a change from alanine to arginine at position 72 (ref. <a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820286">22</a>) it is predicted to adopt a distinct conformation (\'type 3\') that presents loop residues 3 and 4 to the antigen (rather than residues 4 and 5 in type 2 loops). The specific somatic mutation at position 4, from asparagine to methionine, presumably promotes H5 binding. It is not possible to predict the structure of the larger H3 loop, but a tyrosine located at the center of the loop may play an analogous role to that in F10.</p><p id="Par18" class="p p-last">Thus, the F10-H5 crystal structure suggests a common mechanism of H5 virus neutralization for our nAb panel. They make no contact with the receptor binding sites in the head and so do not inhibit cell attachment. Rather, they lock the fusion peptide and helix &#x003b1;A in place, thereby preventing the large structural reorganizations that are required for membrane fusion<sup><a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820291">17</a>,<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820313">19</a>,<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820300">27</a>,<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820288">28</a>,<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820320">29</a>,<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848895183">30</a></sup>. Our data point to this event occurring at an early step in infection, although we cannot rule out the possibility that the nAbs act at a later stage, given the close packing of molecules on the surface of the mature virion, which might restrict early access to the epitope. The only previously published crystal structure of a hemagglutinin-nAb complex that inhibits membrane fusion uses a different mechanism: it prevents conformational changes by cross-linking the upper surfaces of adjacent subunits in the head<sup><a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820304">31</a></sup>.</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">NAbs bind and neutralize a broad range of group 1 viruses</h3><p id="Par19" class="p p-first">Next we examined all of the available hemagglutinin sequences (total 6,360) in the public influenza sequence database (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Table 3</a> online). Of note, the sequences of the F10 epitope are nearly always conserved within the H5 subtype. Indeed, many epitope residues, especially in HA2, are highly conserved across all 16 hemagglutinin subtypes (<a href="/pmc/articles/PMC2692245/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>Fig. 5</span></a>). This high sequence conservation provides a rationale for the cross-neutralization of the H5N1 virus clades described above, and this prompted us to test our antibodies against a broader range of hemagglutinin subtypes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC2692245/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978424521472" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig5_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig5_HTML.jpg" /></div><div id="largeobj_idm139978424521472" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sequence conservation in hemagglutinin groups, clusters and subtypes at the F10 epitope.</strong><p id="__p7">Circles below residue numbers indicate estimated contribution to the binding energy at each position: red, strong; yellow, intermediate; blue, neutral. Residues without a circle are not directly involved in the epitope but are discussed in the text. Colored highlighting on the sequences indicates conservation within clusters and groups, with orange indicating high conservation or invariance. Other colors (for example, yellow, cyan and pink) highlight residues that are cluster or subtype specific. The network of interhelical contacts that stabilize the fusogenic structure<sup><a href="#CR61" rid="CR61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820278">61</a></sup> are indicated below the HA2 sequences. Subtypes that can be recognized/neutralized by F10 are indicated with \'+\' on the far right. (+) or (&#x02212;) indicates a predicted positive or negative binding, respectively.</p></div></div></div><p id="Par20">Group 1 viruses, which contain 10 of the 16 subtypes, are further classified into three \'clusters\': H1a, H1b and H9 (refs. <a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820277">32</a>,<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820334">33</a>; <a href="/pmc/articles/PMC2692245/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>Fig. 5</span></a>). We tested nAb binding to eight members of clusters H1a, H1b and H9, which include avian H5 and the most common human influenza subtypes (the major exception is the group 2 subtype, H3). In addition to H5, we found that all three IgG1s bound to cells expressing full-length H1 from three different strains of H1N1, including the 1918 Spanish flu, H2 from H2N2 and H6 from H6N2, the Cluster 1b subtypes H11 from H11N9, H13 from H13N6 and H16 from H16N3, and the Cluster H9 subtypes from three H9N2 strains. However, none of them bound to a group 2 subtype, H7 from H7N1 (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 7</a> online).</p><p id="Par21" class="p p-last">The IgG1s also neutralized H5-, H1-, H2-, H6- and H11-pseudotyped virus infections (<a href="/pmc/articles/PMC2692245/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>Fig. 6a</span></a>). In a microneutralization assay, F10-IgG1 also neutralized H5N1, H1N1, H2N2, H6N1, H6N2, H8N4 and H9N2 influenza viruses (<a href="/pmc/articles/PMC2692245/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>Fig. 6b</span></a>). However, none of the nAbs neutralized group 2 viruses, for example, H3N2 (<a href="/pmc/articles/PMC2692245/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>Fig. 6b</span></a> and <a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 8</a> online). Thus, these nAbs recognize an epitope on hemagglutinin that is conserved among H5 clades and in all members of group 1 viruses. Finally, we demonstrated the <em>in vivo</em> protective efficacy of two of the IgG1s against two lethal H1N1 viral strains in a BALB/c mouse model, using the same protocol as for the H5N1 studies (<a href="/pmc/articles/PMC2692245/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>Fig. 6c,d</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC2692245/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978416624272" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig6_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig6_HTML.jpg" /></div><div id="largeobj_idm139978416624272" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Cross-subtype neutralization by nAbs.</strong><p id="__p8">(<strong>a</strong>) nAbs D8, F10 and A66 all neutralized indicated pseudotyped viruses (strains described below). Error bars indicate s.d. (<strong>b</strong>) Microneutralization assay. Neutralization titers (0.1 mg ml<sup>&#x02212;1</sup> antibody stock solution) of nAb F10 against wild-type H5N1, H1N1, H2N2, H6N1, H6N2, H8N4, H9N2 and H3N2 virus strains. 80R is the negative control. Vertical bars and whiskers represent the lowest and the highest neutralization titer (2<sup>&#x003c7;</sup>, values of &#x003c7; are shown on the <em>y</em> axis), respectively, of two or three independent experiments. (<strong>c,d</strong>) Prophylactic efficacy against two H1N1 strains in mice. Percentage of survival of mice treated with anti-H5 nAbs or control mAb are shown before lethal challenge by intranasal inoculation with H1-WSN33 (<strong>c</strong>) or H1-PR34 (<strong>d</strong>) viruses. Complete viral strain designations are: H1-OH83 (A/Ohio/83 (H1N1)); H1-PR34 (A/Puerto Rico/8/34 (H1N1)); H1-SC1918 (A/South Carolina/1/1918 (H1N1)); H1-WSN33 (A/WSN/1933 (H1N1)); H2-AA60 (A/Ann Arbor/6/60 (H2N2)); H2-JP57 (A/Japan/305/57(H2N2)); H3-SY97 (A/Sydney/5/97(H3N2)); H6-HK99 (A/quail/Hong Kong/1721-30/99(H6N1)); H6-NY98 (A/chicken/New York/14677-13/1998 (H6N2)); H7-FP34 (A/FPV/Rostock/34 (H7N1)); H8-ON68 (A/turkey/Ontario/6118/68); H9-HK(G9)97 (A/chicken/HongKong/G9/97 (H9N2)); H9-HK99 (A/HongKong/1073/99 (H9N2)); H11-MP74 (A/duck/Memphis/546/74 (H11N9)).</p></div></div></div></div><div id="Sec9" class="sec"><h3 id="Sec9title">Basis of the group-specific broad-spectrum virus neutralization</h3><p id="Par22" class="p p-first">The ability of our nAbs to recognize all group 1 (cluster H1a/b and H9) viruses (H12 was not tested) can be attributed to the key conserved features of the nAbs described above in combination with the highly conserved pocket on hemagglutinin (<a href="/pmc/articles/PMC2692245/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>Figs. 4</span></a> and <a href="/pmc/articles/PMC2692245/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and5).</span></span><span>5</span></a>). The epitope may be divided into three elements. (i) At its center, the sequence of the N-terminal segment of HA2&#x02014;fusion peptide residues 18<sub>2</sub>&#x02013;21<sub>2</sub>&#x02014;is conserved across all hemagglutinin subtypes (note that the side chain at position 19<sub>2</sub> does not participate in binding). (ii) A downstream segment of HA2 adopts part of the &#x003b1;A helix (residues 39<sub>2</sub>&#x02013;56<sub>2</sub>), which is nearly invariant; the only significant difference is a threonine to glutamine change at position 49<sub>2</sub> in the untested H9 cluster subtype, H12. Thr49<sub>2</sub> lies at the periphery of the epitope and makes one long hydrogen bond (3.5 &#x000c5;) to Ser31. Simple modeling suggests that there is plenty of space to accommodate the larger glutamine side chain and that it can make comparable hydrogen bonds. (iii) Smaller contributions from segments of the HA1 chain (residues 18<sub>1</sub> and 38<sub>1</sub>) and a loop at the base of the head (residues 291<sub>1</sub> and 292<sub>1</sub>).</p><p id="Par23" class="p p-last">Three-dimensional comparisons of the epitope in the five known crystal structure subtypes (three from group 1 (H1, H5 and H9) and two from group 2 (H3 and H7)<sup><a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820308">21</a>,<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820273">32</a>,<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820292">34</a>,<a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820333">35</a>,<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820276">36</a></sup>) show that they adopt two distinct structural classes consistent with the phylogenetic groupings<sup><a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820310">32</a>,<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820332">33</a></sup> (<a href="/pmc/articles/PMC2692245/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>Fig. 7</span></a>). These differences arise from group-specific differences in the location of buried residues, notably histidines (H111<sub>2</sub> is unique to group 1; H17<sub>1</sub> is unique to group 2) that have been proposed to be the \'triggers\' for pH-induced conformational changes<sup><a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820303">29</a></sup>. The differences cause the side chain of Trp21<sub>2</sub> to turn through 90&#x000b0; in group 2 subtypes, eliminating favorable binding to Phe55 from our nAb panel. In addition, four out of six group 2 subtypes are glycosylated at position 38<sub>1</sub>, at the periphery of the F10 epitope; our modeling studies predict steric clashes with the CDR-H1 loop (data not shown). These structural differences rationalize the observed lack of binding and neutralization of group 2 hemagglutinin subtypes and viruses.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC2692245/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978418123888" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig7_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 41594_2009_Article_BFnsmb1566_Fig7_HTML.jpg" src="/pmc/articles/PMC2692245/bin/41594_2009_Article_BFnsmb1566_Fig7_HTML.jpg" /></div><div id="largeobj_idm139978418123888" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC2692245/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Three-dimensional comparison of the F10 epitope in group 1 and group 2 hemagglutinins.</strong><p id="__p9">Stereo overlay of crystal structures of the five known hemagglutinin subtypes in the region of the F10 epitope, showing conservation and differences between the two phylogenetic groups. H1, H5 and H9 (group 1) are in shades of red and yellow (PDB <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1RU7" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1RU7</a>, <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2IBX" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2IBX</a> and <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1JSD" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1JSD</a>); H3 and H7 (group 2) are in shades of blue (PDB <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1MQL" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1MQL</a> and <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1TI8" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1TI8</a>). R.m.s. differences for pairwise overlays are 0.56 &#x000b1; 0.11 &#x000c5; (observed range, group 1), 0.75 &#x000c5; (group 2) and 1.21 &#x000b1; 0.12 &#x000c5; between groups. Consistent differences between phylogenetic groups include the orientation of Trp21<sub>2</sub> and alternative side chain directions at 18<sub>1</sub> and 38<sub>1</sub>, which are linked to the packing of buried His111<sub>2</sub> (the putative pH trigger in group 1; absent in group 2), and the burial of the larger tyrosine (group 1) versus histidine (the putative pH trigger in group 2) at 17<sub>1</sub>. Of particular note, Asn38<sub>1</sub> is glycosylated in four members of the group 2 clusters. Other epitope residues are indicated by numbered light blue circles.</p></div></div></div></div><div id="Sec10" class="sec sec-last"><h3 id="Sec10title">Prospects for immune escape</h3><p id="Par24" class="p p-first">The remarkable transformation to the fusogenic state includes repacking of the central helices of three HA2 protomers to form a new triple-helical bundle, in which residues 34&#x02013;37 form an N-terminal cap, and the creation of C-terminal arms that extend to the N terminus of the new bundle<sup><a href="#CR37" rid="CR37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820283">37</a></sup>. It is straightforward to model the locations of the F10 epitope residues in this model of the fusogenic state (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Note 1</a> online). All eight epitope residues, which were fully exposed in the neutral pH structure, become either part of the new hydrophobic bundle core (Thr41<sub>2</sub>, Ile45<sub>2</sub>, Val52<sub>2</sub> and Ile56<sub>2</sub>) or they make networks of hydrogen bonds with the C-terminal arms and other elements that stabilize the new bundle (Lys 38<sub>2</sub>, Gln42<sub>2</sub>, Thr49<sub>2</sub> and Asn53<sub>2</sub>). The requirement for adopting two entirely different conformations, each with a distinct hydrophobic core and hydrogen-bonding network may place powerful evolutionary constraints on the sequence of the helix, as evidenced by the almost complete lack of genetic drift within helix &#x003b1;A among the 16 hemagglutinin subtypes.</p><p id="Par25" class="p p-last">To test this hypothesis, we attempted to select neutralization-escape mutants. We propagated VN/04 (H5N1) virus in MDCK cells for 72 h in the presence of 40 &#x003bc;g ml<sup>&#x02212;1</sup> of each of the 3 nAbs as well as a murine antibody, 22F, that targets the receptor binding head. Following three <em>in vitro</em> passages, we readily isolated a mutant VN04 virus (K193E) that was resistant to 22F. In contrast, we failed to identify any viruses resistant to any of our three IgG1s (D8, F10 or A66). Although these experiments cannot prove that escape mutants with unimpaired viral fitness will never arise, they clearly support the notion that the pocket is more refractory than epitopes in the head. Notwithstanding, if such mutants should arise, we can use our <em>in vitro</em> approach to find new reactive nAbs, or further engineer the existing nAbs to have even broader spectrum reactivity<sup><a href="#CR38" rid="CR38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820282">38</a></sup>.</p></div></div><div id="Sec11" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec11title">Discussion</h2><p id="Par26" class="p p-first">Before the present study, the vast majority of nAbs isolated against influenza A virus have targeted the receptor binding head and lacked broad cross-neutralizing activity. However, a murine nAb, termed C179 (ref. <a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820315">39</a>), was positively selected on the basis of its cross-neutralization properties (of H1 and H2 subtypes) and was subsequently shown to neutralize H5, but not group 2, subtypes<sup><a href="#CR39" rid="CR39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820281">39</a>,<a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820309">40</a></sup> (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Note 2</a> online). Moreover, C179 was shown to block membrane fusion rather than cell attachment and to protect mice against viral challenge<sup><a href="#CR41" rid="CR41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820297">41</a></sup>, although a detailed mechanism was not reported. We compared the activities of C179 and F10 and found that both showed similar binding toward H5. We also found that F10 efficiently competed with C179 for binding to H5, but not vice versa (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Fig. 9</a> online). Furthermore, the point mutant V52<sub>2</sub>E abrogated binding to both antibodies, whereas T318<sub>1</sub>K affected only C179 binding. These results suggest that F10 and C179 have partially overlapping epitopes and that their modes of action are similar.</p><p id="Par27">The manner in which hemagglutinin was presented to the antibody phage-display library in this study seems to have been crucial in our success, because similar attempts to isolate broadly nAbs using cell-surface expressed hemagglutinin showed only partial success against H5, and most antibodies recognized linear epitopes<sup><a href="#CR42" rid="CR42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820314">42</a></sup>. As noted above, we repeatedly isolated nAbs that use the same VH germline gene (<em>IGHV1-69</em> or \'<em>VH1-69</em>\'). One published study pointed out that this is the only VH gene that consistently encodes two hydrophobic residues at the tip of its CDR-H2 loop<sup><a href="#CR43" rid="CR43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820311">43</a></sup>; indeed, it is the only germline gene to encode a phenylalanine at this position, which makes several crucial interactions with H5. Moreover, the \'type 2\' H2 loop, which is long and compact, is predicted to occur in only 4 out of the &#x0223c;50 human germline genes. These factors may explain at least in part the ability of nAbs derived from this germline gene to cross-react with viral epitopes through their unusual ability to bind to conserved hydrophobic pockets. Such pockets are likely to have an important function and for this reason they are often cryptic in the unactivated state of the antigen. For example, <em>VH1-69</em> is the predominant gene used by a group of CD4-induced nAbs raised against the HIV-1 surface glycoprotein, gp120, where the pocket is part of a conserved co-receptor binding site that is exposed only transiently upon binding to its primary receptor, CD4 (ref. <a href="#CR43" rid="CR43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820271">43</a>). Similarly, an antibody raised against the HIV gp41 trimeric \'inner-core\' fusion protein intermediate uses the hydrophobic tip of its VH1-69 CDR-H2 loop to insert into a conserved hydrophobic pocket that blocks further assembly to the fusion-competent six-helix structure<sup><a href="#CR44" rid="CR44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820330">44</a></sup>. <em>In vivo</em>, B cells carrying the <em>VH1-69</em> gene are the primary mediators of innate defense against HCV infection, generating antibodies against its membrane-fusion glycoprotein, E2 (ref. <a href="#CR45" rid="CR45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820285">45</a>), although the epitope and mode of action have not been determined. Notably, as we found here, <em>VH1-69</em> is not the only germline gene that is suitable for achieving neutralization in a similar manner. Another recent example is a nAb against the Ebola virus surface glycoprotein, KZ52, which uses the <em>VH3-21</em> germline gene<sup><a href="#CR46" rid="CR46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820319">46</a></sup>. However, their common ability to lock viral envelope proteins into a nonfusogenic conformation suggests a general strategy for broad-spectrum and/or potent viral neutralization.</p><p id="Par28">Recent work using immune-based phage-display libraries generated from B cell populations of patients who survived H5N1 infection resulted in the isolation of three human nAbs that neutralized both H1 and H5 viral strains. The authors postulated that the reason for survival was an effective humoral immune response mediated by such nAb-generating B cells <em>in vivo</em><sup><a href="#CR47" rid="CR47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820306">47</a></sup>, although no control populations were studied. Analysis of their data (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Note 3</a> online) indicates that the antibodies are also derived from the <em>VH1-69</em> germline gene and share other key characteristics, including the methionine-phenylalanine pair in CDR-H2 and a tyrosine at the tip of CDR-H3. Thus it would seem, at least in this case, that our non-immune (H5-naive) donor library approach generated antibodies with characteristics similar to those found using immunized donor&#x02013;based phage-display libraries derived from H5N1 survivors.</p><p id="Par29">Why broad-spectrum nAbs similar to those identified in our study are not similarly generated and expanded during successive rounds of influenza infection and repeated vaccination is not known (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Note 4</a> online), and this question warrants further investigation. It is unlikely that the F10 epitope provokes self-tolerance mechanism(s) via auto-antigen mimicry<sup><a href="#CR48" rid="CR48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820302">48</a></sup> (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Note 5</a> online). Rather, we hypothesize that an immunodominant antibody response to the highly exposed globular head may overwhelm the antibody response to the F10 epitope, although it remains possible that other immune exclusion mechanism(s) may preclude natural antibody responses against it. It is not surprising that many viruses are highly adept at keeping their most crucial (and conserved) determinants of pathogenesis cryptic, in which case subunit-based vaccines, using properly presented fragments of F10 or F10-like epitopes, may offer distinct advantages over whole virus&#x02013;based approaches to induce broad spectrum nAbs <em>in vivo</em><sup><a href="#CR49" rid="CR49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820293">49</a>,<a href="#CR50" rid="CR50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820312">50</a></sup>.</p><p id="Par30">In summary, we have used <em>in vitro</em> methodologies to isolate a family of high-affinity broad-spectrum human nAbs against hemagglutinin that show potent <em>in vitro</em> and <em>in vivo</em> efficacy against both highly pathogenic H5N1 and H1N1 viruses. We show that they inhibit the post-attachment fusion process by recognizing a highly conserved epitope within the stem region of hemagglutinin at a point where key elements of the conformational change are brought into close apposition. Our initial experiments suggest that this region is recalcitrant to the generation of escape mutants. The prospects for their use for passive immunotherapy would therefore seem to be excellent, either alone or in combination with small-molecule inhibitors (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Note 6</a> online). Finally, our structural work pinpoints the reasons why group 2 hemagglutinins do not bind the nAbs described here: despite surface sequence similarities, they form a structurally distinct group, but one that is also highly conserved and therefore may be amenable to a similar panning discovery approach.</p><p id="Par31" class="p p-last"><em>Note added in proof: Throsby et al.</em><sup><a href="#CR51" rid="CR51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820318">51</a></sup><em> recently identified human nAbs that recognize a broad range of group 1 influenza A viruses with similar VH1-69 germline gene usage</em>.</p></div><div id="Sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec12title">Methods</h2><div id="Sec13" class="sec sec-first"><h3 id="Sec13title">Crystallization of the H5&#x02013;F10 complex.</h3><p id="Par32" class="p p-first-last">We generated H5&#x02013;F10 complexes by incubating the two purified components with an excess of F10 (<a href="#MOESM13" rid="MOESM13" class=" media">Supplementary Methods</a> online) and isolated them by Superdex 200 in Tris-buffered saline (TBS) buffer. Peak fractions were pooled and concentrated to &#x0223c;11 mg ml<sup>&#x02212;1</sup>. We examined the integrity of the H5 trimer using gel filtration and SDS-PAGE. Crystals grew at 22 &#x000b0;C by equilibrating equal volumes of protein and reservoir solution (12.5% PEG 1K (w/v), 25% ethylene glycol (w/v), 100 mM Tris, pH 8.5) using the hanging drop vapor diffusion technique.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Data collection, structure determination and refinement.</h3><p id="Par33" class="p p-first-last">We collected diffraction data from crystals that were flash frozen at 100 K in the reservoir buffer at the Stanford Synchrotron Radiation Laboratory beamline 9.2, set at a wavelength of 1.0 &#x000c5; and processed with XDS<sup><a href="#CR52" rid="CR52" class=" bibr popnode">52</a></sup> and HKL2000 (ref. <a href="#CR53" rid="CR53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845250312">53</a>). The structure was solved at 3.2-&#x000c5; resolution by molecular replacement with PHASER using the structures of H5 (A/Vietnam/1194/04; PDB <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2IBX" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2IBX</a>) and a homology model of F10 based on the structure of SARS nAb 80R (PDB <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2GHW" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2GHW</a>)<sup><a href="#CR54" rid="CR54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820325">54</a>,<a href="#CR55" rid="CR55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820336">55</a></sup> as starting models. The asymmetric unit contains two H5 trimers and three F10 molecules per trimer and was refined using REFMAC5 (ref. <a href="#CR56" rid="CR56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820280">56</a>) with simulated annealing in CNS and manual rebuilding with Coot<sup><a href="#CR57" rid="CR57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820321">57</a></sup> and Xtalview<sup><a href="#CR58" rid="CR58" class=" bibr popnode">58</a></sup>. The final maps are of high quality, and key features such as the F10 CDR loops and interfacial residues are unambiguous and consistent in the six copies. The final model includes 503, 503, 503, 497, 497 and 497 residues for the six independent copies of H5; 235, 235, 236, 233, 234 and 234 residues for the six F10scFvs; 24 <em>N</em>-acetyl-<span class="small-caps">D</span>-glucosamine and six &#x003b2;-<span class="small-caps">D</span>-mannose units, but no water molecules. The <em>R</em><sub>free</sub> is 0.29 with excellent geometry as assessed with PROCHECK<sup><a href="#CR59" rid="CR59" class=" bibr popnode">59</a></sup> and Rampage (<a href="/pmc/articles/PMC2692245/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>Table 1</span></a>): residues in the favored, allowed and outlier regions are 90.0%, 9.5% and 0.5%, respectively.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p10">Data collection and refinement statistics for H5&#x02013;F10</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978429365616" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1">Native H5&#x02013;F10</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">\n<strong>Data collection</strong>\n</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Space group</td><td rowspan="1" colspan="1">\n<em>C2</em>\n</td></tr><tr><td rowspan="1" colspan="1">Cell dimensions</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">\n<em>a</em>, <em>b</em>, <em>c</em> (&#x000c5;)</td><td rowspan="1" colspan="1">205, 119, 339</td></tr><tr><td rowspan="1" colspan="1">\n<em>&#x003b1;</em>, <em>&#x003b2;</em>, <em>&#x003b3;</em> (&#x000b0;)</td><td rowspan="1" colspan="1">90, 99.6, 90</td></tr><tr><td rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td rowspan="1" colspan="1">3.2 (3.28&#x02013;3.20)<sup>*</sup></td></tr><tr><td rowspan="1" colspan="1">\n<em>R</em>\n<sub>merge</sub>\n</td><td rowspan="1" colspan="1">0.13 (0.81)</td></tr><tr><td rowspan="1" colspan="1"><em>I</em> / &#x003c3;<em>I</em></td><td rowspan="1" colspan="1">9.5 (2.0)</td></tr><tr><td rowspan="1" colspan="1">Completeness (%)</td><td rowspan="1" colspan="1">85 (68)</td></tr><tr><td rowspan="1" colspan="1">Redundancy</td><td rowspan="1" colspan="1">4.5 (4.5)</td></tr><tr><td rowspan="1" colspan="1">\n<strong>Refinement</strong>\n</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td rowspan="1" colspan="1">50&#x02013;3.2 (3.28&#x02013;3.20)</td></tr><tr><td rowspan="1" colspan="1">No. reflections</td><td rowspan="1" colspan="1">106,885</td></tr><tr><td rowspan="1" colspan="1"><em>R</em><sub>work</sub> / <em>R</em><sub>free</sub></td><td rowspan="1" colspan="1">0.23 (0.32)/0.29 (0.38)</td></tr><tr><td rowspan="1" colspan="1">No. atoms</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"> Protein</td><td rowspan="1" colspan="1">34,573</td></tr><tr><td rowspan="1" colspan="1"> Carbohydrate</td><td rowspan="1" colspan="1">402</td></tr><tr><td rowspan="1" colspan="1"> Water</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"><em>B</em>-factors</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"> Protein</td><td rowspan="1" colspan="1">83.5</td></tr><tr><td rowspan="1" colspan="1"> Carbohydrate</td><td rowspan="1" colspan="1">123.7</td></tr><tr><td rowspan="1" colspan="1">r.m.s. deviations</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"> Bond lengths (&#x000c5;)</td><td rowspan="1" colspan="1">0.010</td></tr><tr><td rowspan="1" colspan="1"> Bond angles (&#x000b0;)</td><td rowspan="1" colspan="1">1.31</td></tr></tbody></table></div><div id="largeobj_idm139978429365616" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2692245/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p11">A single crystal was used for both structure determination at 3.2-&#x000c5; resolution and refinement.</p><p id="__p12"><sup>*</sup>Values in parentheses are for highest-resolution shell.</p></div></div></div><div id="Sec15" class="sec"><h3 id="Sec15title">Phage-display library selection.</h3><p id="Par34" class="p p-first-last">We produced recombinant trimeric H5-VN04 ectodomain as for crystallization studies except that we did not use furin co-infection to ensure complete activation. Antibodies were identified by two rounds of selection of a 27 billion&#x02013;membered human scFv phage-display library against recombinant trimeric H5 immobilized on Immunotube (Nunc), followed by ELISA screening. We identified ten unique anti-H5 antibodies by sequence analysis of 97 H5-positive clones out of 392 clones screened.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Plaque reduction assay.</h3><p id="Par35" class="p p-first-last">H5-VN04, H5-IN05 or A/Netherland/219/03 (H7N7) (H7-NL03) viruses (10,000 plaque forming units (p.f.u.)) were incubated with anti-H5 scFv-Fcs at three different concentrations (1 &#x003bc;g ml<sup>&#x02212;1</sup>, 10 &#x003bc;g ml<sup>&#x02212;1</sup>or 100 &#x003bc;g ml<sup>&#x02212;1</sup>) at 37 &#x000b0;C for 30 min. We diluted the virus-antibody mixture logarithmically and transferred the dilutions onto MDCK cell monolayers in 12-well plates, which we then incubated at 37 &#x000b0;C for 1 h. The cells were then washed and overlaid with agar. After 4 d of incubation, we discarded the overlay and the plaques were visualized by crystal violet staining.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Microneutralization assay.</h3><p id="Par36" class="p p-first-last">We carried out the assay as described<sup><a href="#CR60" rid="CR60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820307">60</a></sup>. Briefly, we mixed 100 TCID<sub>50</sub> (median tissue culture infectious doses) of virus in equal volume with two-fold serial dilutions of antibody stock solution (0.1 mg ml<sup>&#x02212;1</sup>) in 96-well plates and incubated them for 1 h at 37 &#x000b0;C. Indicator MDCK cells (1.5 &#x000d7; 10<sup>4</sup> cells per well) were added to the plates, followed by incubation at 37 &#x000b0;C for 20 h. To establish the endpoint, we washed the cell monolayers with PBS, fixed the cells in acetone and detected viral antigen by indirect ELISA with a mAb against influenza A NP (A-3, Accurate).</p></div><div id="Sec18" class="sec"><h3 id="Sec18title">Viral binding inhibition assay.</h3><p id="Par37" class="p p-first-last">We incubated 0.5 &#x000d7; 10<sup>6</sup> 293T cells with H5-TH04&#x02013;pseudotyped HIV viruses (&#x0223c;500 ng of p24) in the presence of anti-H5 nAbs or control mAbs, or in the absence of antibodies, in PBS buffer containing 0.5% (w/v) BSA and 0.02% (w/v) NaN<sub>3</sub> at 4 &#x000b0;C. After 1 h of incubation, cells were spun down, and the supernatants were tested for p24 levels using an HIV-1 p24<sup>CA</sup> capture ELISA kit (National Cancer Institute, US National Institutes of Health) to quantify unbound virus. Cells were then washed once or twice and lysed to quantify the cell-bound virus using the same method.</p></div><div id="Sec19" class="sec"><h3 id="Sec19title">Cell fusion inhibition assay.</h3><p id="Par38" class="p p-first-last">We transfected HeLa cells, &#x0223c;90% confluent in six-well plates, with pcDNA3.1-H5-TH04 plasmid (3 &#x003bc;g total DNA per well) using lipofectamine 2000 (Invitrogen). After &#x0223c;30 h of transfection, the culture medium was supplemented with 1 ml of anti-H5 or control mAbs for 1&#x02013;2 h, and cells were then washed and incubated with low-pH fusion buffer (150 mM NaCl plus 10 mM HEPES, adjusted to pH 5.0) for 4&#x02013;5 min. Cells were then returned to the standard culture medium for 2&#x02013;3 h at 37 &#x000b0;C, and finally fixed with 0.25% (v/v) glutaraldehyde and stained with 0.1% (w/v) crystal violet. Photomicrographs were taken at 10&#x000d7; magnification.</p></div><div id="Sec20" class="sec"><h3 id="Sec20title">Prophylactic and therapeutic efficacy studies in mice.</h3><p id="Par39" class="p p-first">We used female 8&#x02013;10 weeks old BALB/c mice in all experiments. Mice were weighed on the day of virus challenge and then daily for 2 weeks. We used body weight as the clinical endpoint; mice with body weight loss &#x02265;25% of pre-infection values were euthanized. Animal studies were conducted as per the approved Institutional Animal Care and Use Committee protocols.</p><p id="Par40">For the prophylactic efficacy study, three human nAbs (D8-IgG1, F10-IgG1 and A66-IgG1) or control human mAb 80R-IgG1 (ref. <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844820274">18</a>) at 2.5 mg kg<sup>&#x02212;1</sup> or 10 mg kg<sup>&#x02212;1</sup> were administered into four groups of five mice each by intraperitoneal injection in a 0.5 ml volume. At 1 h after mAb administration, two groups of mice were challenged with H5-VN04 and two groups with H5-HK97 intranasal inoculation with 10 MLD<sub>50</sub> in 50 &#x003bc;l volumes per mouse. Mice were observed and weighed daily for 2 weeks after infection. Analogous studies were performed to evaluate the protective efficacy of the nAbs against A/Puerto Rico/8/1934 (H1N1) or A/WSN/1933 (H1N1) viruses.</p><p id="Par41" class="p p-last">For the post-exposure therapy efficacy study, the experimental design recapitulates the prophylaxis study, with the following exceptions. We first inoculated 12 groups of ten mice intranasally with 10 MLD<sub>50</sub> of VN04. At 24 h, 48 h and 72 h after H5-VN04 infection, the mice received intraperitoneal injections of 15 mg kg<sup>&#x02212;1</sup> body weight of one of the nAbs or control (80R).</p></div><div id="Sec21" class="sec sec-last"><h3 id="Sec21title">Accession codes.</h3><p id="Par42" class="p p-first">Protein Data Bank: Coordinates and structure factors for the H5&#x02013;F10 complex have been deposited with accession code <a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=3FKU" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">3FKU</a>.</p><p id="Par43" class="p p-last"><em>Note: </em><a href="#MOESM13" rid="MOESM13" class=" media"><em>Supplementary information</em></a><em> is available on the Nature Structural &#x00026; Molecular Biology website</em>.</p></div></div><div id="__sec3" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="__sec3title">Supplementary information</h2><!--/article/body/sec/--><div id="Sec22" class="sec sec-first-last"><p id="__p13" class="p p-first-last">\n</p><div class="sec suppmat" id="MOESM13"><div class="sup-box half_rhythm" id="idm139978429705408"><a href="/pmc/articles/PMC2692245/bin/41594_2009_BFnsmb1566_MOESM13_ESM.pdf" data-ga-action="click_feat_suppl">Supplementary Figures 1&#x02013;9, Supplementary Tables 1&#x02013;3, Supplementary Notes 1&#x02013;6 and Supplementary Methods (PDF 847 kb)</a><sup>(848K, pdf)</sup></div></div><p>\n</p></div></div><div id="idm139978462290736" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139978462290736title">Acknowledgements</h2><div class="sec"><p id="__p16">We thank J. Appleton (Cornell University) for the gift of mouse mAbs against H5N1, 17A2.1.2 and 22F; A. Klimov (CDC) and A. Balish (CDC) for providing ferret antiserum and virus sequences; R. Webster (St. Jude Children\'s Research Hospital) for H11N9, H13N6 and H16N3; L. Quynh Mai (National Institute of Hygiene and Epidemiology, Vietnam Ministry of Health) for H5N1; W. Lim (Hong Kong Department of Health) for H5N1 and H9N2, as well as E. Sedyaningsih, T. Soendoro (National Institute of Health Research and Development, Indonesian Ministry of Health) for H5N1 specimens; P. Palese (Mount Sinai School of Medicine) for pCAGGS-H1(SC) plasmid encoding the full-length hemagglutinin protein of H1-SC1918; M. Farzan (New England Primate Research Center, Harvard Medical School) for pCAGGS-H1 (PR) plasmid encoding the hemagglutinin protein of H1-PR34 and X. Yang (Beth Israel Deaconess Medical Center, Harvard Medical School) for pCAGGS-H7 (FPV) encoding H7-FP34 hemagglutinin; and R. Fuller (University of Michigan) for furin cDNA. We thank W. Yuan and W. Li for helpful discussions and Y. Lin for assistance in crystallization and critical discussion. We thank the US National Institutes of Health (NIH) and the Department of Energy (DOE) for access to the Stanford Synchrotron Radiation Facility and the facility staff for assistance in X-ray data collection. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081). This work was supported by NIH (U01-AI074518-01) to W.A.M. and in part by NIH (P01-AI055789) to R.C.L.</p></div></div><div id="idm139978462288064" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139978462288064title">Author Contributions</h2><p id="__p17">In the DFCI team, J.S. and A.M. constructed H5-TH04 hemagglutinin; J.S. and D.A. performed phage-display antibody library selections and screening for antibodies by ELISA, FACS and pseudovirus-neutralization assays; J.S., M.A. and T.H. carried out epitope mapping using mutagenesis and FACS analysis; J.S., D.A. and M.A. purified antibodies; J.S. and A.Y. analyzed kinetics of antibody binding with hemagglutinin protein; J.S. performed hemagglutinin subtype cross-binding and neutralization assays, pseudovirus binding and fusion inhibition assay; J.S. and W.A.M. designed the study, analyzed data and wrote the sections about these studies. In the BIMR team, R.C.L. supervised all of the work; G.W. and G.C. cloned and expressed recombinant H5 for antibody panning and crystallization. W.C.H. expressed F10 scFv and crystallized the F10&#x02013;HA0 complex; W.C.H., E.S. and B.S. collected diffraction data and solved and refined the structure; L.A.B. supervised cloning and expression; W.C.H., L.A.B. and R.C.L. wrote sections about these studies. In the CDC team, S.P., L.C., H.W., N.J.C. and R.O.D. designed the study and performed animal studies as well as virology studies with wild-type viruses; R.O.D wrote sections of these studies; J.S., R.O.D., R.C.L. and W.A.M. finalized the paper. All authors commented on the manuscript.</p><p id="__p18">The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention or the Agency for Toxic Substances and Disease Registry.</p></div><div id="idm139978462286016" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139978462286016title">Accession codes</h2><div id="d29e1701" class="sec sec-first"><h2 id="d29e1701title">Primary accessions</h2><p id="Par45" class="p p-first-last">\n</p><h4 style="clear:both">Protein Data Bank</h4><ul class="unordered" style="list-style-type:disc"><!--\nlist-behavior=unordered\nprefix-word=\nmark-type=disc\nmax-label-size=0\n--><li><p id="Par46">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=3FKU" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">3FKU</a>\n</p></li></ul><p>\n</p></div><div id="d29e1718" class="sec sec-last"><h2 id="d29e1718title">Referenced accessions</h2><p id="Par47" class="p p-first-last">\n</p><h4 style="clear:both">Protein Data Bank</h4><ul class="unordered" style="list-style-type:disc"><!--\nlist-behavior=unordered\nprefix-word=\nmark-type=disc\nmax-label-size=0\n--><li><p id="Par48">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1JSD" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1JSD</a>\n</p></li><li><p id="Par49">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1MQL" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1MQL</a>\n</p></li><li><p id="Par50">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1RU7" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1RU7</a>\n</p></li><li><p id="Par51">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=1TI8" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">1TI8</a>\n</p></li><li><p id="Par52">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2GHW" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2GHW</a>\n</p></li><li><p id="Par53">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2HMG" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2HMG</a>\n</p></li><li><p id="Par54">\n<a href="http://www.pdb.org/pdb/search/structidSearch.do?structureId=2IBX" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">2IBX</a>\n</p></li></ul><p>\n</p></div></div><div id="idm139978462291584" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139978462291584title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139978462291456"><p id="__p15" class="p p-first-last">Jianhua Sui and William C Hwang: These authors contributed equally to this work.</p></p></div></div><div id="idm139978422060064aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139978422060064aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Jianhua Sui, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.icfd@ius_auhnaij" class="oemail">ude.dravrah.icfd@ius_auhnaij</a></span>.</p><p><span class="fm-affl">Ruben O Donis, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.cdc@6dvr" class="oemail">vog.cdc@6dvr</a></span>.</p><p><span class="fm-affl">Robert C Liddington, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.mahnrub@gniddilr" class="oemail">gro.mahnrub@gniddilr</a></span>.</p><p><span class="fm-affl">Wayne A Marasco, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.icfd@ocsaram_enyaw" class="oemail">ude.dravrah.icfd@ocsaram_enyaw</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="mixed-citation">WHO. Factsheet 211: influenza. <em>World Health Organization</em> &#x03008;<a href="http://www.who.int/mediacentre/factsheets/2003/fs211/en/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/mediacentre/factsheets/2003/fs211/en/</a>&#x03009; (2003).</span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Webster RG. 1918 Spanish influenza: the secrets remain elusive. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>1999;<span class="ref-vol">96</span>:1164\xe2\x80\x931166. doi: 10.1073/pnas.96.4.1164.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC33548/">PMC free article</a>]</span> [<a href="/pubmed/9989993" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.96.4.1164" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=1918+Spanish+influenza:+the+secrets+remain+elusive&amp;author=RG+Webster&amp;volume=96&amp;publication_year=1999&amp;pages=1164-1166&amp;pmid=9989993&amp;doi=10.1073/pnas.96.4.1164&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">de Wit E, Fouchier RA. Emerging influenza. <span><span class="ref-journal">J. Clin. Virol. </span>2008;<span class="ref-vol">41</span>:1\xe2\x80\x936. doi: 10.1016/j.jcv.2007.10.017.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2768345/">PMC free article</a>]</span> [<a href="/pubmed/18340670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jcv.2007.10.017" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Virol.&amp;title=Emerging+influenza&amp;author=E+de+Wit&amp;author=RA+Fouchier&amp;volume=41&amp;publication_year=2008&amp;pages=1-6&amp;pmid=18340670&amp;doi=10.1016/j.jcv.2007.10.017&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="mixed-citation">WHO. Global influenza surveillance. <em>World Health Organization</em> &#x03008;<a href="http://www.who.int/csr/disease/influenza/influenzanetwork/en/index.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/csr/disease/influenza/influenzanetwork/en/index.html</a>&#x03009; (2008).</span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. <span><span class="ref-journal">Vaccine. </span>2007;<span class="ref-vol">25</span>:6852\xe2\x80\x936862. doi: 10.1016/j.vaccine.2007.07.027.</span> [<a href="/pubmed/17719149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.vaccine.2007.07.027" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Influenza+vaccine:+the+challenge+of+antigenic+drift&amp;author=F+Carrat&amp;author=A+Flahault&amp;volume=25&amp;publication_year=2007&amp;pages=6852-6862&amp;pmid=17719149&amp;doi=10.1016/j.vaccine.2007.07.027&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Cinatl J, Jr, Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part IV: development of vaccines. <span><span class="ref-journal">Med. Microbiol. Immunol. </span>2007;<span class="ref-vol">196</span>:213\xe2\x80\x93225. doi: 10.1007/s00430-007-0052-3.</span> [<a href="/pubmed/17541633" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00430-007-0052-3" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med.+Microbiol.+Immunol.&amp;title=The+threat+of+avian+influenza+A+(H5N1).+Part+IV:+development+of+vaccines&amp;author=J+Cinatl&amp;author=M+Michaelis&amp;author=HW+Doerr&amp;volume=196&amp;publication_year=2007&amp;pages=213-225&amp;pmid=17541633&amp;doi=10.1007/s00430-007-0052-3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Subbarao K, Luke C. H5N1 viruses and vaccines. <span><span class="ref-journal">PLoS Pathog. </span>2007;<span class="ref-vol">3</span>:e40. doi: 10.1371/journal.ppat.0030040.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1808069/">PMC free article</a>]</span> [<a href="/pubmed/17335350" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.ppat.0030040" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog.&amp;title=H5N1+viruses+and+vaccines&amp;author=K+Subbarao&amp;author=C+Luke&amp;volume=3&amp;publication_year=2007&amp;pages=e40&amp;pmid=17335350&amp;doi=10.1371/journal.ppat.0030040&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Leroux-Roels I, et al.  Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. <span><span class="ref-journal">PLoS ONE. </span>2008;<span class="ref-vol">3</span>:e1665. doi: 10.1371/journal.pone.0001665.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2253495/">PMC free article</a>]</span> [<a href="/pubmed/18301743" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0001665" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Broad+clade+2+cross-reactive+immunity+induced+by+an+adjuvanted+clade+1+rH5N1+pandemic+influenza+vaccine&amp;author=I+Leroux-Roels&amp;volume=3&amp;publication_year=2008&amp;pages=e1665&amp;pmid=18301743&amp;doi=10.1371/journal.pone.0001665&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Baras B, et al.  Cross-Protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. <span><span class="ref-journal">PLoS ONE. </span>2008;<span class="ref-vol">3</span>:e1401. doi: 10.1371/journal.pone.0001401.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2151135/">PMC free article</a>]</span> [<a href="/pubmed/18167560" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0001401" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Cross-Protection+against+lethal+H5N1+challenge+in+ferrets+with+an+adjuvanted+pandemic+influenza+vaccine&amp;author=B+Baras&amp;volume=3&amp;publication_year=2008&amp;pages=e1401&amp;pmid=18167560&amp;doi=10.1371/journal.pone.0001401&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">de Jong MD, et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. <span><span class="ref-journal">N. Engl. J. Med. </span>2005;<span class="ref-vol">353</span>:2667\xe2\x80\x932672. doi: 10.1056/NEJMoa054512.</span> [<a href="/pubmed/16371632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa054512" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med.&amp;title=Oseltamivir+resistance+during+treatment+of+influenza+A+(H5N1)+infection&amp;author=MD+de+Jong&amp;volume=353&amp;publication_year=2005&amp;pages=2667-2672&amp;pmid=16371632&amp;doi=10.1056/NEJMoa054512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="mixed-citation">WHO. Clinical management of human infection with avian influenza A (H5N1) virus. <em>World Health Organization</em> &#x03008;<a href="http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/csr/disease/avian_influenza/&#x000a0;guidelines/ClinicalManagement07.pdf</a>&#x03009; (2007).</span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Wright P, Neumann G, Kawaoka Y.  <span class="ref-journal">Fields Virology.</span> 2006. Orthomyxoviruses; pp. 1692\xe2\x80\x931740. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Fields+Virology&amp;author=P+Wright&amp;author=G+Neumann&amp;author=Y+Kawaoka&amp;publication_year=2006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Fauci AS. Pandemic influenza threat and preparedness. <span><span class="ref-journal">Emerg. Infect. Dis. </span>2006;<span class="ref-vol">12</span>:73\xe2\x80\x9377. doi: 10.3201/eid1201.050983.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3291399/">PMC free article</a>]</span> [<a href="/pubmed/16494721" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.3201%2Feid1201.050983" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg.+Infect.+Dis.&amp;title=Pandemic+influenza+threat+and+preparedness&amp;author=AS+Fauci&amp;volume=12&amp;publication_year=2006&amp;pages=73-77&amp;pmid=16494721&amp;doi=10.3201/eid1201.050983&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Marasco WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. <span><span class="ref-journal">Nat. Biotechnol. </span>2007;<span class="ref-vol">25</span>:1421\xe2\x80\x931434. doi: 10.1038/nbt1363.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7097443/">PMC free article</a>]</span> [<a href="/pubmed/18066039" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnbt1363" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Biotechnol.&amp;title=The+growth+and+potential+of+human+antiviral+monoclonal+antibody+therapeutics&amp;author=WA+Marasco&amp;author=J+Sui&amp;volume=25&amp;publication_year=2007&amp;pages=1421-1434&amp;pmid=18066039&amp;doi=10.1038/nbt1363&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="mixed-citation">WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. <em>World Health Organization</em> &#x03008;<a href="http://www.who.int/csr/disease/avian_influenza/guidelines/summaryH520070403.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/csr/disease/avian_influenza/guidelines/&#x000a0;summaryH520070403.pdf</a>&#x03009; (2007). [<a href="/pubmed/17500103" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="mixed-citation">World Health Organization Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. <em>Emerg. Infect. Dis.</em><strong>11</strong>, 1515&#x02013;1521 (2005). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3366754/">PMC free article</a>]</span> [<a href="/pubmed/16318689" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Stevens J, et al.  Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">312</span>:404\xe2\x80\x93410. doi: 10.1126/science.1124513.</span> [<a href="/pubmed/16543414" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1124513" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Structure+and+receptor+specificity+of+the+hemagglutinin+from+an+H5N1+influenza+virus&amp;author=J+Stevens&amp;volume=312&amp;publication_year=2006&amp;pages=404-410&amp;pmid=16543414&amp;doi=10.1126/science.1124513&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Sui J, et al.  Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>2004;<span class="ref-vol">101</span>:2536\xe2\x80\x932541. doi: 10.1073/pnas.0307140101.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC356985/">PMC free article</a>]</span> [<a href="/pubmed/14983044" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0307140101" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Potent+neutralization+of+severe+acute+respiratory+syndrome+(SARS)+coronavirus+by+a+human+mAb+to+S1+protein+that+blocks+receptor+association&amp;author=J+Sui&amp;volume=101&amp;publication_year=2004&amp;pages=2536-2541&amp;pmid=14983044&amp;doi=10.1073/pnas.0307140101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. <span><span class="ref-journal">Annu. Rev. Biochem. </span>2000;<span class="ref-vol">69</span>:531\xe2\x80\x93569. doi: 10.1146/annurev.biochem.69.1.531.</span> [<a href="/pubmed/10966468" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev.biochem.69.1.531" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu.+Rev.+Biochem.&amp;title=Receptor+binding+and+membrane+fusion+in+virus+entry:+the+influenza+hemagglutinin&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=69&amp;publication_year=2000&amp;pages=531-569&amp;pmid=10966468&amp;doi=10.1146/annurev.biochem.69.1.531&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Kida H, Yoden S, Kuwabara M, Yanagawa R. Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism. <span><span class="ref-journal">Vaccine. </span>1985;<span class="ref-vol">3</span>:219\xe2\x80\x93222. doi: 10.1016/0264-410X(85)90110-0.</span> [<a href="/pubmed/4060852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0264-410X(85)90110-0" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Interference+with+a+conformational+change+in+the+haemagglutinin+molecule+of+influenza+virus+by+antibodies+as+a+possible+neutralization+mechanism&amp;author=H+Kida&amp;author=S+Yoden&amp;author=M+Kuwabara&amp;author=R+Yanagawa&amp;volume=3&amp;publication_year=1985&amp;pages=219-222&amp;pmid=4060852&amp;doi=10.1016/0264-410X(85)90110-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Ha Y, Stevens DJ, Skehel JJ, Wiley DC. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. <span><span class="ref-journal">EMBO J. </span>2002;<span class="ref-vol">21</span>:865\xe2\x80\x93875. doi: 10.1093/emboj/21.5.865.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC125880/">PMC free article</a>]</span> [<a href="/pubmed/11867515" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Femboj%2F21.5.865" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J.&amp;title=H5+avian+and+H9+swine+influenza+virus+haemagglutinin+structures:+possible+origin+of+influenza+subtypes&amp;author=Y+Ha&amp;author=DJ+Stevens&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=21&amp;publication_year=2002&amp;pages=865-875&amp;pmid=11867515&amp;doi=10.1093/emboj/21.5.865&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Chothia C, et al.  Structural repertoire of the human VH segments. <span><span class="ref-journal">J. Mol. Biol. </span>1992;<span class="ref-vol">227</span>:799\xe2\x80\x93817. doi: 10.1016/0022-2836(92)90224-8.</span> [<a href="/pubmed/1404389" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0022-2836(92)90224-8" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Mol.+Biol.&amp;title=Structural+repertoire+of+the+human+VH+segments&amp;author=C+Chothia&amp;volume=227&amp;publication_year=1992&amp;pages=799-817&amp;pmid=1404389&amp;doi=10.1016/0022-2836(92)90224-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Samanta U, Pal D, Chakrabarti P. Packing of aromatic rings against tryptophan residues in proteins. <span><span class="ref-journal">Acta Crystallogr. D Biol. Crystallogr. </span>1999;<span class="ref-vol">55</span>:1421\xe2\x80\x931427. doi: 10.1107/S090744499900726X.</span> [<a href="/pubmed/10417410" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1107%2FS090744499900726X" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr.+D+Biol.+Crystallogr.&amp;title=Packing+of+aromatic+rings+against+tryptophan+residues+in+proteins&amp;author=U+Samanta&amp;author=D+Pal&amp;author=P+Chakrabarti&amp;volume=55&amp;publication_year=1999&amp;pages=1421-1427&amp;pmid=10417410&amp;doi=10.1107/S090744499900726X&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Weis WI, Brunger AT, Skehel JJ, Wiley DC. Refinement of the influenza virus hemagglutinin by simulated annealing. <span><span class="ref-journal">J. Mol. Biol. </span>1990;<span class="ref-vol">212</span>:737\xe2\x80\x93761. doi: 10.1016/0022-2836(90)90234-D.</span> [<a href="/pubmed/2329580" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0022-2836(90)90234-D" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Mol.+Biol.&amp;title=Refinement+of+the+influenza+virus+hemagglutinin+by+simulated+annealing&amp;author=WI+Weis&amp;author=AT+Brunger&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=212&amp;publication_year=1990&amp;pages=737-761&amp;pmid=2329580&amp;doi=10.1016/0022-2836(90)90234-D&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Pal D, Chakrabarti P. Non-hydrogen bond interactions involving the methionine sulfur atom. <span><span class="ref-journal">J. Biomol. Struct. Dyn. </span>2001;<span class="ref-vol">19</span>:115\xe2\x80\x93128. doi: 10.1080/07391102.2001.10506725.</span> [<a href="/pubmed/11565843" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F07391102.2001.10506725" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biomol.+Struct.+Dyn.&amp;title=Non-hydrogen+bond+interactions+involving+the+methionine+sulfur+atom&amp;author=D+Pal&amp;author=P+Chakrabarti&amp;volume=19&amp;publication_year=2001&amp;pages=115-128&amp;pmid=11565843&amp;doi=10.1080/07391102.2001.10506725&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Champ PC, Camacho CJ. FastContact: a free energy scoring tool for protein-protein complex structures. <span><span class="ref-journal">Nucleic Acids Res. </span>2007;<span class="ref-vol">35</span>:W556\xe2\x80\x93W560. doi: 10.1093/nar/gkm326.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1933237/">PMC free article</a>]</span> [<a href="/pubmed/17537824" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgkm326" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=FastContact:+a+free+energy+scoring+tool+for+protein-protein+complex+structures&amp;author=PC+Champ&amp;author=CJ+Camacho&amp;volume=35&amp;publication_year=2007&amp;pages=W556-W560&amp;pmid=17537824&amp;doi=10.1093/nar/gkm326&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Stevens J, et al.  Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">303</span>:1866\xe2\x80\x931870. doi: 10.1126/science.1093373.</span> [<a href="/pubmed/14764887" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1093373" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Structure+of+the+uncleaved+human+H1+hemagglutinin+from+the+extinct+1918+influenza+virus&amp;author=J+Stevens&amp;volume=303&amp;publication_year=2004&amp;pages=1866-1870&amp;pmid=14764887&amp;doi=10.1126/science.1093373&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Daniels RS, et al.  Fusion mutants of the influenza virus hemagglutinin glycoprotein. <span><span class="ref-journal">Cell. </span>1985;<span class="ref-vol">40</span>:431\xe2\x80\x93439. doi: 10.1016/0092-8674(85)90157-6.</span> [<a href="/pubmed/3967299" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0092-8674(85)90157-6" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Fusion+mutants+of+the+influenza+virus+hemagglutinin+glycoprotein&amp;author=RS+Daniels&amp;volume=40&amp;publication_year=1985&amp;pages=431-439&amp;pmid=3967299&amp;doi=10.1016/0092-8674(85)90157-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Thoennes S, et al.  Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. <span><span class="ref-journal">Virology. </span>2008;<span class="ref-vol">370</span>:403\xe2\x80\x93414. doi: 10.1016/j.virol.2007.08.035.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2212604/">PMC free article</a>]</span> [<a href="/pubmed/17936324" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virol.2007.08.035" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Analysis+of+residues+near+the+fusion+peptide+in+the+influenza+hemagglutinin+structure+for+roles+in+triggering+membrane+fusion&amp;author=S+Thoennes&amp;volume=370&amp;publication_year=2008&amp;pages=403-414&amp;pmid=17936324&amp;doi=10.1016/j.virol.2007.08.035&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Earp LJ, Delos SE, Park HE, White JM. The many mechanisms of viral membrane fusion proteins. <span><span class="ref-journal">Curr. Top. Microbiol. Immunol. </span>2005;<span class="ref-vol">285</span>:25\xe2\x80\x9366.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7122167/">PMC free article</a>]</span> [<a href="/pubmed/15609500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Top.+Microbiol.+Immunol.&amp;title=The+many+mechanisms+of+viral+membrane+fusion+proteins&amp;author=LJ+Earp&amp;author=SE+Delos&amp;author=HE+Park&amp;author=JM+White&amp;volume=285&amp;publication_year=2005&amp;pages=25-66&amp;pmid=15609500&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Barbey-Martin C, et al.  An antibody that prevents the hemagglutinin low pH fusogenic transition. <span><span class="ref-journal">Virology. </span>2002;<span class="ref-vol">294</span>:70\xe2\x80\x9374. doi: 10.1006/viro.2001.1320.</span> [<a href="/pubmed/11886266" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fviro.2001.1320" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=An+antibody+that+prevents+the+hemagglutinin+low+pH+fusogenic+transition&amp;author=C+Barbey-Martin&amp;volume=294&amp;publication_year=2002&amp;pages=70-74&amp;pmid=11886266&amp;doi=10.1006/viro.2001.1320&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Russell RJ, et al.  H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. <span><span class="ref-journal">Virology. </span>2004;<span class="ref-vol">325</span>:287\xe2\x80\x93296. doi: 10.1016/j.virol.2004.04.040.</span> [<a href="/pubmed/15246268" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virol.2004.04.040" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=H1+and+H7+influenza+haemagglutinin+structures+extend+a+structural+classification+of+haemagglutinin+subtypes&amp;author=RJ+Russell&amp;volume=325&amp;publication_year=2004&amp;pages=287-296&amp;pmid=15246268&amp;doi=10.1016/j.virol.2004.04.040&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Fouchier RA, et al.  Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. <span><span class="ref-journal">J. Virol. </span>2005;<span class="ref-vol">79</span>:2814\xe2\x80\x932822. doi: 10.1128/JVI.79.5.2814-2822.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC548452/">PMC free article</a>]</span> [<a href="/pubmed/15709000" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.79.5.2814-2822.2005" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=Characterization+of+a+novel+influenza+A+virus+hemagglutinin+subtype+(H16)+obtained+from+black-headed+gulls&amp;author=RA+Fouchier&amp;volume=79&amp;publication_year=2005&amp;pages=2814-2822&amp;pmid=15709000&amp;doi=10.1128/JVI.79.5.2814-2822.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Gamblin SJ, et al.  The structure and receptor binding properties of the 1918 influenza hemagglutinin. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">303</span>:1838\xe2\x80\x931842. doi: 10.1126/science.1093155.</span> [<a href="/pubmed/14764886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1093155" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+structure+and+receptor+binding+properties+of+the+1918+influenza+hemagglutinin&amp;author=SJ+Gamblin&amp;volume=303&amp;publication_year=2004&amp;pages=1838-1842&amp;pmid=14764886&amp;doi=10.1126/science.1093155&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Yamada S, et al.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. <span><span class="ref-journal">Nature. </span>2006;<span class="ref-vol">444</span>:378\xe2\x80\x93382. doi: 10.1038/nature05264.</span> [<a href="/pubmed/17108965" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnature05264" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Haemagglutinin+mutations+responsible+for+the+binding+of+H5N1+influenza+A+viruses+to+human-type+receptors&amp;author=S+Yamada&amp;volume=444&amp;publication_year=2006&amp;pages=378-382&amp;pmid=17108965&amp;doi=10.1038/nature05264&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Ha Y, Stevens DJ, Skehel JJ, Wiley DC. X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. <span><span class="ref-journal">Virology. </span>2003;<span class="ref-vol">309</span>:209\xe2\x80\x93218. doi: 10.1016/S0042-6822(03)00068-0.</span> [<a href="/pubmed/12758169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0042-6822(03)00068-0" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=X-ray+structure+of+the+hemagglutinin+of+a+potential+H3+avian+progenitor+of+the+1968+Hong+Kong+pandemic+influenza+virus&amp;author=Y+Ha&amp;author=DJ+Stevens&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=309&amp;publication_year=2003&amp;pages=209-218&amp;pmid=12758169&amp;doi=10.1016/S0042-6822(03)00068-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Chen J, Skehel JJ, Wiley DC. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA<sub>2</sub> subunit to form an N cap that terminates the triple-stranded coiled coil. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>1999;<span class="ref-vol">96</span>:8967\xe2\x80\x938972. doi: 10.1073/pnas.96.16.8967.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC17716/">PMC free article</a>]</span> [<a href="/pubmed/10430879" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.96.16.8967" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=N-+and+C-terminal+residues+combine+in+the+fusion-pH+influenza+hemagglutinin+HA2+subunit+to+form+an+N+cap+that+terminates+the+triple-stranded+coiled+coil&amp;author=J+Chen&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=96&amp;publication_year=1999&amp;pages=8967-8972&amp;pmid=10430879&amp;doi=10.1073/pnas.96.16.8967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Sui J, et al.  Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. <span><span class="ref-journal">PLoS Pathog. </span>2008;<span class="ref-vol">4</span>:e1000197. doi: 10.1371/journal.ppat.1000197.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2572002/">PMC free article</a>]</span> [<a href="/pubmed/18989460" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.ppat.1000197" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog.&amp;title=Broadening+of+neutralization+activity+to+directly+block+a+dominant+antibody-driven+SARS-coronavirus+evolution+pathway&amp;author=J+Sui&amp;volume=4&amp;publication_year=2008&amp;pages=e1000197&amp;pmid=18989460&amp;doi=10.1371/journal.ppat.1000197&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Okuno Y, Isegawa Y, Sasao F, Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. <span><span class="ref-journal">J. Virol. </span>1993;<span class="ref-vol">67</span>:2552\xe2\x80\x932558.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC237575/">PMC free article</a>]</span> [<a href="/pubmed/7682624" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol.&amp;title=A+common+neutralizing+epitope+conserved+between+the+hemagglutinins+of+influenza+A+virus+H1+and+H2+strains&amp;author=Y+Okuno&amp;author=Y+Isegawa&amp;author=F+Sasao&amp;author=S+Ueda&amp;volume=67&amp;publication_year=1993&amp;pages=2552-2558&amp;pmid=7682624&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Smirnov YA, et al.  An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. <span><span class="ref-journal">Acta Virol. </span>1999;<span class="ref-vol">43</span>:237\xe2\x80\x93244.</span> [<a href="/pubmed/10749369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Virol.&amp;title=An+epitope+shared+by+the+hemagglutinins+of+H1,+H2,+H5,+and+H6+subtypes+of+influenza+A+virus&amp;author=YA+Smirnov&amp;volume=43&amp;publication_year=1999&amp;pages=237-244&amp;pmid=10749369&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Smirnov YA, Lipatov AS, Gitelman AK, Claas EC, Osterhaus AD. Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region. <span><span class="ref-journal">Arch. Virol. </span>2000;<span class="ref-vol">145</span>:1733\xe2\x80\x931741. doi: 10.1007/s007050070088.</span> [<a href="/pubmed/11003481" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs007050070088" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Virol.&amp;title=Prevention+and+treatment+of+bronchopneumonia+in+mice+caused+by+mouse-adapted+variant+of+avian+H5N2+influenza+A+virus+using+monoclonal+antibody+against+conserved+epitope+in+the+HA+stem+region&amp;author=YA+Smirnov&amp;author=AS+Lipatov&amp;author=AK+Gitelman&amp;author=EC+Claas&amp;author=AD+Osterhaus&amp;volume=145&amp;publication_year=2000&amp;pages=1733-1741&amp;pmid=11003481&amp;doi=10.1007/s007050070088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Lim AP, et al.  Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library. <span><span class="ref-journal">Virol. J. </span>2008;<span class="ref-vol">5</span>:130. doi: 10.1186/1743-422X-5-130.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2582236/">PMC free article</a>]</span> [<a href="/pubmed/18957074" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1743-422X-5-130" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virol.+J.&amp;title=Neutralizing+human+monoclonal+antibody+against+H5N1+influenza+HA+selected+from+a+Fab-phage+display+library&amp;author=AP+Lim&amp;volume=5&amp;publication_year=2008&amp;pages=130&amp;pmid=18957074&amp;doi=10.1186/1743-422X-5-130&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Huang CC, et al.  Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>2004;<span class="ref-vol">101</span>:2706\xe2\x80\x932711. doi: 10.1073/pnas.0308527100.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC365685/">PMC free article</a>]</span> [<a href="/pubmed/14981267" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0308527100" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Structural+basis+of+tyrosine+sulfation+and+VH-gene+usage+in+antibodies+that+recognize+the+HIV+type+1+coreceptor-binding+site+on+gp120&amp;author=CC+Huang&amp;volume=101&amp;publication_year=2004&amp;pages=2706-2711&amp;pmid=14981267&amp;doi=10.1073/pnas.0308527100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Luftig MA, et al.  Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. <span><span class="ref-journal">Nat. Struct. Mol. Biol. </span>2006;<span class="ref-vol">13</span>:740\xe2\x80\x93747. doi: 10.1038/nsmb1127.</span> [<a href="/pubmed/16862157" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnsmb1127" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Struct.+Mol.+Biol.&amp;title=Structural+basis+for+HIV-1+neutralization+by+a+gp41+fusion+intermediate-directed+antibody&amp;author=MA+Luftig&amp;volume=13&amp;publication_year=2006&amp;pages=740-747&amp;pmid=16862157&amp;doi=10.1038/nsmb1127&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Chan CH, Hadlock KG, Foung SK, Levy S. <em>V</em><sub><em>H</em></sub><em>1&#x02013;69</em> gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">97</span>:1023\xe2\x80\x931026. doi: 10.1182/blood.V97.4.1023.</span> [<a href="/pubmed/11159532" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1182%2Fblood.V97.4.1023" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=VH1&#x02013;69+gene+is+preferentially+used+by+hepatitis+C+virus-associated+B+cell+lymphomas+and+by+normal+B+cells+responding+to+the+E2+viral+antigen&amp;author=CH+Chan&amp;author=KG+Hadlock&amp;author=SK+Foung&amp;author=S+Levy&amp;volume=97&amp;publication_year=2001&amp;pages=1023-1026&amp;pmid=11159532&amp;doi=10.1182/blood.V97.4.1023&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Lee JE, et al.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">454</span>:177\xe2\x80\x93182. doi: 10.1038/nature07082.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2700032/">PMC free article</a>]</span> [<a href="/pubmed/18615077" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnature07082" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure+of+the+Ebola+virus+glycoprotein+bound+to+an+antibody+from+a+human+survivor&amp;author=JE+Lee&amp;volume=454&amp;publication_year=2008&amp;pages=177-182&amp;pmid=18615077&amp;doi=10.1038/nature07082&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Kashyap AK, et al.  Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>2008;<span class="ref-vol">105</span>:5986\xe2\x80\x935991. doi: 10.1073/pnas.0801367105.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2329690/">PMC free article</a>]</span> [<a href="/pubmed/18413603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0801367105" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Combinatorial+antibody+libraries+from+survivors+of+the+Turkish+H5N1+avian+influenza+outbreak+reveal+virus+neutralization+strategies&amp;author=AK+Kashyap&amp;volume=105&amp;publication_year=2008&amp;pages=5986-5991&amp;pmid=18413603&amp;doi=10.1073/pnas.0801367105&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Scherer EM, Zwick MB, Teyton L, Burton DR. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. <span><span class="ref-journal">AIDS. </span>2007;<span class="ref-vol">21</span>:2131\xe2\x80\x932139. doi: 10.1097/QAD.0b013e3282a4a632.</span> [<a href="/pubmed/18090039" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2FQAD.0b013e3282a4a632" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=Difficulties+in+eliciting+broadly+neutralizing+anti-HIV+antibodies+are+not+explained+by+cardiolipin+autoreactivity&amp;author=EM+Scherer&amp;author=MB+Zwick&amp;author=L+Teyton&amp;author=DR+Burton&amp;volume=21&amp;publication_year=2007&amp;pages=2131-2139&amp;pmid=18090039&amp;doi=10.1097/QAD.0b013e3282a4a632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Selvarajah S, et al.  Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140. <span><span class="ref-journal">AIDS Res. Hum. Retroviruses. </span>2008;<span class="ref-vol">24</span>:301\xe2\x80\x93314. doi: 10.1089/aid.2007.0158.</span> [<a href="/pubmed/18284327" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1089%2Faid.2007.0158" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AIDS+Res.+Hum.+Retroviruses&amp;title=Focused+dampening+of+antibody+response+to+the+immunodominant+variable+loops+by+engineered+soluble+gp140&amp;author=S+Selvarajah&amp;volume=24&amp;publication_year=2008&amp;pages=301-314&amp;pmid=18284327&amp;doi=10.1089/aid.2007.0158&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="element-citation">Scheerlinck JP, et al.  Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein. <span><span class="ref-journal">Mol. Immunol. </span>1993;<span class="ref-vol">30</span>:733\xe2\x80\x93739. doi: 10.1016/0161-5890(93)90144-Z.</span> [<a href="/pubmed/7684820" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0161-5890(93)90144-Z" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Immunol.&amp;title=Redistribution+of+a+murine+humoral+immune+response+following+removal+of+an+immunodominant+B+cell+epitope+from+a+recombinant+fusion+protein&amp;author=JP+Scheerlinck&amp;volume=30&amp;publication_year=1993&amp;pages=733-739&amp;pmid=7684820&amp;doi=10.1016/0161-5890(93)90144-Z&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR51">51. <span class="element-citation">Throsby M, et al.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM<sup>+</sup> memory B cells. <span><span class="ref-journal">PLoS ONE. </span>2008;<span class="ref-vol">3</span>:e3942. doi: 10.1371/journal.pone.0003942.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2596486/">PMC free article</a>]</span> [<a href="/pubmed/19079604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0003942" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Heterosubtypic+neutralizing+monoclonal+antibodies+cross-protective+against+H5N1+and+H1N1+recovered+from+human+IgM++memory+B+cells&amp;author=M+Throsby&amp;volume=3&amp;publication_year=2008&amp;pages=e3942&amp;pmid=19079604&amp;doi=10.1371/journal.pone.0003942&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR52">52. <span class="element-citation">Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. <span><span class="ref-journal">J. Appl. Cryst. </span>1993;<span class="ref-vol">26</span>:795\xe2\x80\x93800. doi: 10.1107/S0021889893005588.</span> [<a href="//dx.doi.org/10.1107%2FS0021889893005588" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Appl.+Cryst.&amp;title=Automatic+processing+of+rotation+diffraction+data+from+crystals+of+initially+unknown+symmetry+and+cell+constants&amp;author=W+Kabsch&amp;volume=26&amp;publication_year=1993&amp;pages=795-800&amp;doi=10.1107/S0021889893005588&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR53">53. <span class="element-citation">Otwinowski ZO, Minor W. Processing of X-ray diffraction data collected in oscillation mode. <span><span class="ref-journal">Methods Enzymol. </span>1997;<span class="ref-vol">276</span>:307\xe2\x80\x93326. doi: 10.1016/S0076-6879(97)76066-X.</span> [<a href="/pubmed/27754618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0076-6879(97)76066-X" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Enzymol.&amp;title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&amp;author=ZO+Otwinowski&amp;author=W+Minor&amp;volume=276&amp;publication_year=1997&amp;pages=307-326&amp;doi=10.1016/S0076-6879(97)76066-X&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR54">54. <span class="element-citation">Hwang WC, et al.  Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. <span><span class="ref-journal">J. Biol. Chem. </span>2006;<span class="ref-vol">281</span>:34610\xe2\x80\x9334616. doi: 10.1074/jbc.M603275200.</span> [<a href="/pubmed/16954221" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.M603275200" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem.&amp;title=Structural+basis+of+neutralization+by+a+human+anti-severe+acute+respiratory+syndrome+spike+protein+antibody,+80R&amp;author=WC+Hwang&amp;volume=281&amp;publication_year=2006&amp;pages=34610-34616&amp;pmid=16954221&amp;doi=10.1074/jbc.M603275200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR55">55. <span class="element-citation">Rodriguez R, Chinea G, Lopez N, Pons T, Vriend G. Homology modeling, model and software evaluation: three related resources. <span><span class="ref-journal">Bioinformatics. </span>1998;<span class="ref-vol">14</span>:523\xe2\x80\x93528. doi: 10.1093/bioinformatics/14.6.523.</span> [<a href="/pubmed/9694991" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fbioinformatics%2F14.6.523" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Homology+modeling,+model+and+software+evaluation:+three+related+resources&amp;author=R+Rodriguez&amp;author=G+Chinea&amp;author=N+Lopez&amp;author=T+Pons&amp;author=G+Vriend&amp;volume=14&amp;publication_year=1998&amp;pages=523-528&amp;pmid=9694991&amp;doi=10.1093/bioinformatics/14.6.523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR56">56. <span class="element-citation">Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. <span><span class="ref-journal">Acta Crystallogr. D Biol. Crystallogr. </span>1997;<span class="ref-vol">53</span>:240\xe2\x80\x93255. doi: 10.1107/S0907444996012255.</span> [<a href="/pubmed/15299926" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1107%2FS0907444996012255" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr.+D+Biol.+Crystallogr.&amp;title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&amp;author=GN+Murshudov&amp;author=AA+Vagin&amp;author=EJ+Dodson&amp;volume=53&amp;publication_year=1997&amp;pages=240-255&amp;pmid=15299926&amp;doi=10.1107/S0907444996012255&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR57">57. <span class="element-citation">Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. <span><span class="ref-journal">Acta Crystallogr. D Biol. Crystallogr. </span>2004;<span class="ref-vol">60</span>:2126\xe2\x80\x932132. doi: 10.1107/S0907444904019158.</span> [<a href="/pubmed/15572765" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1107%2FS0907444904019158" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr.+D+Biol.+Crystallogr.&amp;title=Coot:+model-building+tools+for+molecular+graphics&amp;author=P+Emsley&amp;author=K+Cowtan&amp;volume=60&amp;publication_year=2004&amp;pages=2126-2132&amp;pmid=15572765&amp;doi=10.1107/S0907444904019158&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR58">58. <span class="element-citation">McRee DE. A visual protein crystallographic software system for X11/Xview. <span><span class="ref-journal">J. Mol. Graph. </span>1992;<span class="ref-vol">10</span>:44\xe2\x80\x9346. doi: 10.1016/0263-7855(92)80022-6.</span> [<a href="//dx.doi.org/10.1016%2F0263-7855(92)80022-6" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Mol.+Graph.&amp;title=A+visual+protein+crystallographic+software+system+for+X11/Xview&amp;author=DE+McRee&amp;volume=10&amp;publication_year=1992&amp;pages=44-46&amp;doi=10.1016/0263-7855(92)80022-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR59">59. <span class="element-citation">Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. <span><span class="ref-journal">J. Appl. Cryst. </span>1993;<span class="ref-vol">26</span>:283\xe2\x80\x93291. doi: 10.1107/S0021889892009944.</span> [<a href="//dx.doi.org/10.1107%2FS0021889892009944" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Appl.+Cryst.&amp;title=PROCHECK:+a+program+to+check+the+stereochemical+quality+of+protein+structures&amp;author=RA+Laskowski&amp;author=MW+MacArthur&amp;author=DS+Moss&amp;author=JM+Thornton&amp;volume=26&amp;publication_year=1993&amp;pages=283-291&amp;doi=10.1107/S0021889892009944&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR60">60. <span class="element-citation">Rowe T, et al.  Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. <span><span class="ref-journal">J. Clin. Microbiol. </span>1999;<span class="ref-vol">37</span>:937\xe2\x80\x93943.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC88628/">PMC free article</a>]</span> [<a href="/pubmed/10074505" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Microbiol.&amp;title=Detection+of+antibody+to+avian+influenza+A+(H5N1)+virus+in+human+serum+by+using+a+combination+of+serologic+assays&amp;author=T+Rowe&amp;volume=37&amp;publication_year=1999&amp;pages=937-943&amp;pmid=10074505&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR61">61. <span class="element-citation">Bullough PA, Hughson FM, Skehel JJ, Wiley DC. Structure of influenza haemagglutinin at the pH of membrane fusion. <span><span class="ref-journal">Nature. </span>1994;<span class="ref-vol">371</span>:37\xe2\x80\x9343. doi: 10.1038/371037a0.</span> [<a href="/pubmed/8072525" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F371037a0" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structure+of+influenza+haemagglutinin+at+the+pH+of+membrane+fusion&amp;author=PA+Bullough&amp;author=FM+Hughson&amp;author=JJ+Skehel&amp;author=DC+Wiley&amp;volume=371&amp;publication_year=1994&amp;pages=37-43&amp;pmid=8072525&amp;doi=10.1038/371037a0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2692245&amp;issue-id=354832&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2692245/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2692245/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2692245/pdf/41594_2009_Article_BFnsmb1566.pdf">PDF (1.1M)</a></li> | <li><a href="#" data-citationid="PMC2692245" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2692245%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2692245%2F&amp;text=Structural%20and%20functional%20bases%20for%20broad-spectrum%20neutralization%20of%20avian%20and%20human%20influenza%20A%20viruses"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2692245%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19234466" data-aiid="7097561" data-aid="2692245" data-iid="354832" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2692245" data-md5="cc5e42e0eaa07fa6198559000378d4df"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T11:32:43-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A0E58E99C766100000000025F025E&amp;ncbi_session=8A1A0E58E99CC1A1_0607SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2692245%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2692245/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A0E58E99CC1A1_0607SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'